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Abstract: GABAA Rezeptoren (GABAAR) vermitteln hemmende Transmission im Gehirn und sind Ziel-
strukturen für z.B. Benzodiazepine, die aufgrund ihrer sedierenden, muskelrelaxierenden, anxiolytischen
und antiepileptischen Wirkung verschrieben werden. Bei chronischem Gebrauch entwickelt sich eine Tol-
eranz gegenüber diesen Effekten, wovon der Mechanismus immer noch unbekannt ist. In dieser Arbeit
wurden zwei Ansätze verfolgt, um die Regulation der GABAAR zu untersuchen. Zuerst befassten wir
uns mit der konstitutiven Internalisierung von GABAAR in kultivierten Neuronen. In einem zweiten
Schritt konzentrierten wir uns auf Toleranz in Mäusen mit spezifische Diazepam-insensitive GABAAR,
um herauszufinden welche GABAAR Subtypen an der Entwicklung von Toleranz beteiligt sind. In der
ersten Studie wurde festgestellt dass Oberflächenrezeptoren homogen über die Membran verteilt waren,
während die endozytierten Rezeptoren zu Clustern in einem subsynaptischen Pool akkumulierten via
Clathrin-coated Vesikeln. Diese Resultate lassen vermuten, dass die Zirkulation von GABAAR zwis-
chen der Zelloberfläche und dem subsynaptischen Pool einen Mechanismus zur Kurzzeit-Regulation der
GABAergen synaptischen Übertragung darstellt. Dieser Regulation könnte durch die chronische Behand-
lung mit Diazepam beeinflusst werden. In der zweiten Studie wurden Mäuse mit einer Punktmutation in
der ￿1-, ￿2-, ￿3- oder ￿5-Untereinheit während 8 Tagen mit Diazepam behandelt. Wildtyp-, ￿2(H101R)- und
￿3(H101R)-Mäuse entwickelten Toleranz gegenüber der sedierenden Wirkung von Diazepam, ausser die
￿1(H101R) Mäuse, da die Punktmutation sie insensitiv gegenüber der Sedierung macht. Die ￿5(H101R)
Mäuse zeigten überhaupt keine sedative Toleranz nach chronischer Behandlung. Diazepam-behandelte
Wildtyp-Mäuse konnten jedoch mit einer einmaligen Dosis Zolpidem, ein ￿1-GABAAR-selektiven Ligand,
sediert werden. Dieser Effekt weist darauf hin, dass die ￿1-GABAAR immer noch funktionell sind. Spezi-
fische Liganden für die ￿5-GABAAR zeigten eine Reduktion von Bindungsstellen im Gyrus Dentatus von
toleranten Mäusen auf Wildtyp und ￿2 (H101R), aber nicht ￿1(H101R). Zusammenfassend schliessen wir,
dass konstitutive Endozytose einen wichtigen Mechanismus zur kurzzeitigen Regulierung von synaptischen
GABAAR darstellt. Sedative Toleranz gegenüber Diazepam aber, entsteht durch Anpassungsmechanis-
men in spezifischen neuronalen Kreisläufen, die durch ￿1- und ￿5- GABAAR kontrolliert werden. Abstract
GABAA receptors (GABAAR) mediate inhibitory neurotransmission in the brain. They are the target
for drugs such as the benzodiazepines, which are prescribed for their sedative, muscle-relaxant, anxiolytic
and anti-epileptic properties. Tolerance to these effects develops after chronic use, but the mechanisms
underlying this remain unknown. We used two approaches to investigate GABAAR regulation. The first
line of research involved the constitutive regulation of GABAAR in cell culture by endocytosis. The aim
was to elucidate whether endocytosis is a possible mechanism for the development of tolerance. As it is
unknown which GABAAR subtypes contribute to tolerance, the second approach concentrated on toler-
ance in mice carrying specific GABAAR subtypes made insensitive to diazepam. In the first study, an
intracellular pool of GABAAR subunits was detected at postsynaptic sites. Although surface GABAAR
were distributed evenly over the membrane, endocytosed receptors acccumulated in a pool underneath
the synapse via clathrin coated vesicles. The intracellular GABAAR pool might provide a mechanism
for short-term modulation. It is possible that this regulation of GABAAR is affected by chronic di-
azepam treatment. In the second study, mice carrying a point mutation in ￿1-, ￿2-, ￿3- or ￿5- subunit
were subjected to an 8-day treatment schedule with diazepam. Wild type, ￿2(H101R) and ￿3(H101R)
mice developed sedative tolerance, whereas ￿1(H101R) mice did not, as the point-mutation renders them
insensitive to sedation by benzodiazepines. The ￿5 (H101R) mice did not show any sedative tolerance
after chronic diazepam treatment. Moreover, diazepam-treated mice were sedated by a single dose of
zolpidem, an ￿1- GABAAR selective ligand, indicating that ￿1-GABAAR remain functional. In addition,
￿5- GABAAR binding sites were only reduced in the dentate gyrus of tolerant wild type and ￿2(H101R)
animals. In conclusion, endocytosis might be involved in short-term regulation of GABAAR, but it is
not the main cause for tolerance to diazepam in vivo. Sedative tolerance is likely caused by adaptive
mechanisms activated by concurrent enhanced GABAergic inhibition of ￿1- and ￿5-GABAAR.
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                                                   Zusammenfassung 
Zusammenfassung 
GABAA Rezeptoren vermitteln den grössten Teil der hemmenden Transmission im Gehirn 
und sind Zielstrukturen für viele Medikamente, wie z.B. Benzodiazepine, die aufgrund ihrer 
sedierenden, muskelrelaxierenden, anxiolytischen und antiepileptischen Wirkung 
verschrieben werden. Bei chronischem Gebrauch entwickelt sich eine Toleranz gegenüber 
diesen Effekten, wobei der Mechanismus, der zu diesem Wirkungsverlust führt, immer noch 
unbekannt ist. 
In der vorliegenden Arbeit wurden zwei voneinander unabhängige Ansätze verfolgt, um die 
Regulation der GABAA Rezeptoren bezüglich der Toleranzentwicklung nach chronischer 
Diazepam-Behandlung zu untersuchen. Zuerst befassten wir uns mit der konstitutiven 
Internalisierung von endogenen GABAA Rezeptoren in kultivierten Neuronen, um zu 
prüfen, inwiefern dieser Regulationsmechanismus zur Toleranzentwicklung beiträgt. In 
einem zweiten Schritt konzentrierten wir uns auf Verhaltensexperimente mit Mäusen mit 
einer Punktmutation, welche spezifische GABAA Rezeptoren Diazepam-insensitiv macht. 
Dabei war das Ziel, herauszufinden welche GABAA Rezeptor Subtypen an der Entwicklung 
von Toleranz gegenüber der sedativen Wirkung von Diazepam beteiligt sind. 
In der ersten Studie benutzten wir immunzytochemische Methoden, um die subzelluläre 
Verteilung von GABAA Rezeptoren in der Membran und deren Translokation aufgrund von 
Internalisierung zu verfolgen. In lebenden hippocampalen Zellen wurden Rezeptoren mit 
Antikörpern markiert, und zwar unter Bedingungen, die Endozytose erlauben. 
Oberflächenrezeptoren waren homogen über die Membran verteilt, während die 
endozytierten Rezeptoren interessanterweise zu deutlich erkennbaren Clustern in einem 
subsynaptischen Pool akkumulierten, der mit Gephyrin assoziiert war. Da dieser Prozess 
zeitabhängig war, vermuten wir, dass internalisierte Rezeptoren zu diesem intrazellulären 
Reservoir umverteilt werden. Die Endozytose erfolgte mit Hilfe von Clathrin-coated 
Vesikeln, denn die Hemmung dieses Mechanismus mit kaltem Puffer, hypertonischer 
Saccharose oder mit einem Dynamin-inhibitierenden Peptid die Intensität der 
internalisierten Cluster massiv reduzierte. Die akute Applikation von GABAA Rezeptor-
Liganden beeinträchtigte das Vorkommen der internalisierten GABAA Rezeptoren jedoch 
nicht. Im Gegensatz dazu wurden AMPA Rezeptoren nach der Einwirkung von Agonisten 
rasch internalisiert und im Zellkörper akkumuliert. Die Existenz eines intrazellulären 
subsynaptischen Pools von GABAA Rezeptoren wurde auch unabhängig von 
Internalisierungsexperimenten nachgewiesen. Diese Resultate lassen vermuten, dass die 
Zirkulation von GABAA Rezeptoren  zwischen der Zelloberfläche und dem subsynaptischen 
Pool einen Mechanismus zur Kurzzeit-Regulation der GABAergen synaptischen 
Übertragung darstellt. Vermutlich könnte dieser Regulationsmechanismus durch die 
chronische Behandlung mit Diazepam beeinflusst werden.  
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                                                   Zusammenfassung 
In der zweiten Studie wurde die Toleranz gegenüber der sedierenden Wirkung von 
Diazepam untersucht, wobei Mäuse mit einer Punktmutation in der α1-, α2-, α3- oder α5-
Untereinheit während 8 Tagen mit dem Sedativum behandelt wurden. Der akut-sedative 
Effekt von Diazepam wird über die α1-GABAA Rezeptoren vermittelt. Wildtyp-, 
α2(H101R)- und α3(H101R)-Mäuse entwickelten Toleranz gegenüber der sedierenden 
Wirkung von Diazepam, was an einer verminderten Unterdrückung der motorischen 
Aktivität gezeigt werden konnte. Die α1(H101R) Mäuse wiesen keinerlei Veränderungen in 
der motorischen Aktivität auf, da die Punktmutation sie insensitiv gegenüber der Sedierung 
durch Diazepam macht. Die α5(H101R) Mäuse zeigten jedoch überhaupt keine sedative 
Toleranz nach chronischer Behandlung mit Diazepam. Daraus schliessen wir, dass die α5-
GABAA Rezeptoren in die Toleranzentwicklung involviert sind. Autoradiographie mit [3H]-
Flumazenil in denselben Mäusen zeigte, dass die Gesamtmenge der GABAA Rezeptor 
Bindungsstellen nach chronischer Diazepam-Behandlung nicht reduziert war. Spezifische 
Liganden für die α5- GABAA Rezeptoren jedoch zeigten eine selektive Reduktion von 
Bindungsstellen im Gyrus Dentatus von toleranten Mäusen auf Wildtyp und α2(H101R), 
aber nicht α1(H101R). Diazepam-behandelte Wildtyp-Mäuse konnten in 
Kontrollexperimenten mit einer einmaligen Dosis Zolpidem sediert werden. Der Effekt 
dieses α1-GABAA Rezeptor-selektiven Liganden weist darauf hin, dass die α1-GABAA 
Rezeptoren auch nach der chronischen Diazepam-Behandlung immer noch funktionell sind. 
Des weitern fanden wir eine transiente Reduktion der motorischen Aktivität bei Wildtyp-
Mäusen, die chronisch mit Zolpidem behandelt wurden, ohne dass die α5-Bindungsstellen 
reduziert worden wären. Zur Toleranzentwicklung aufgrund chronischer Diazepam-
Anwendung, begleitet von einer Verminderung der α5- GABAA Rezeptoren im Gyrus 
Dentatus, müssen also α1- und α5-GABAA Rezeptoren miteinander aktiviert werden. 
Zusammenfassend schliessen wir, dass sedative Toleranz gegenüber Diazepam durch die 
Beteiligung von bestimmten GABAA Rezeptor-Subtypen entsteht und nicht mit einem 
Funktionsverlust von α1- GABAA Rezeptoren assoziiert ist. Wahrscheinlich wird das 
Toleranzphänomen durch Anpassungsmechanismen in spezifischen neuronalen Kreisläufen 
hervorgerufen, die durch α1- und α5-GABAA Rezeptoren kontrolliert werden. Die 
konstitutive Endozytose stellt zwar einen wichtigen Mechanismus zur kurzzeitigen 
Regulierung der synaptischen Funktion von GABAA Rezeptoren dar, nimmt aber im 
Entstehen der Toleranz gegenüber Diazepam in vivo nur eine untergeordnete Rolle ein.  
 II 
 Summary  
Summary 
GABAA receptors  (GABAAR) mediate the major part of inhibitory neurotransmission in 
the brain. They are the target for several drugs such as the benzodiazepines, which are 
prescribed for their sedative, muscle-relaxant, anxiolytic and anti-epileptic properties. 
Tolerance to these properties develops after chronic use, but the mechanisms underlying the 
loss of drug effect remain unknown. 
We used two independent approaches to investigate the mechanisms of GABAAR 
regulation. The first line of research involved the constitutive regulation of GABAAR in cell 
culture by endocytosis. The second approach concentrated on the mechanism of tolerance in 
mice carrying specific GABAAR subtypes made unresponsive to diazepam by a point 
mutation. The aim was to elucidate whether endocytosis is a possible mechanism for the 
development of tolerance. Furthermore, it is unknown if all major GABAAR subtypes 
contribute to the development of tolerance, a question that can be resolved by using mice 
with point-mutations in different GABAAR subtypes. 
In the first study, an intracellular pool of GABAAR subunits was detected at presumptive 
postsynaptic sites. After tagging surface receptors of living hippocampal neurons with 
antibody and allowing for constitutive endocytosis, we found that surface receptors were 
distributed evenly over the membrane. Endocytosed receptors acccumulated in the pool 
underneath the synapse in a time-dependent manner, showing that the internalised receptors 
are relocated to the intracellular pool. The endocytosis occurred via clathrin-coated vesicles, 
as interfering with this pathway by cold buffer, hypertonic sucrose or a dynamin inhibiting 
peptide, greatly reduced the intensity of these internalised clusters. However, acute 
application of GABAAR ligands did not affect the appearance of the internalised GABAAR. 
This is in contrast to AMPA receptors, which are rapidly internalized and accumulated 
within the cell body after agonist exposure. The intracellular GABAAR pool might provide 
a mechanism for short-term modulation of GABAAR and allow for rapid shuttling of 
receptors between the pool and the membrane. It is possible that this regulation of 
GABAAR is affected by chronic diazepam treatment. 
In the second study, mice carrying a point mutation in either the α1-, α2-, α3- or α5- 
subunit were subjected to an 8-day treatment schedule with diazepam. Wild type, 
α2(H101R) and α3(H101R) mice developed tolerance to the sedative properties of 
diazepam, as demonstrated by the loss of motor depression after diazepam administration. 
The α1(H101R) mice did not display any sedation or tolerance, as the point-mutation 
renders them insensitive to sedation by benzodiazepines. The α5(H101R) mice however, 
did not show any sedative tolerance after chronic diazepam treatment, implying that α5- 
GABAAR subtypes are a prerequisite for the development of this tolerance. In addition, α5-
GABAAR binding sites were only reduced in the dentate gyrus of tolerant wild type and 
α2(H101R) animals. This reduction was absent in α1(H101R) mice. Therefore specific 
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concurrent activation of both α1- and α5-GABAAR is required for this effect. We conclude 
that tolerance is the result of the simultaneously increased α1- and α5-mediated inhibition, 
which might lead to a reduction in α5-binding sites and activates adaptive mechanisms 
resulting in tolerance. This view was confirmed in wild type mice chronically treated with 
zolpidem, an α1-GABAAR selective ligand. These mice only displayed a partial motor 
depression after a similar treatment regimen, without any reduction in α5-binding sites. 
This partial tolerance appeared to be the result of a quicker recovery of the mice, as full 
sedation was observed directly after injection. Thus, only α1-mediated sedation is not 
enough to result in full sedative tolerance and the reduction in α5 binding sites. Moreover, 
diazepam-treated mice were sedated by a single dose of zolpidem, indicating that α1-
GABAAR are still functional. This further implies that endocytosis of α1-GABAAR is not a 
major contributor to the development of sedative tolerance to diazepam. 
In conclusion, endocytosis might be a mechanism involved in short-term regulation of 
GABAAR, but it is not the main cause for the development of tolerance to diazepam in vivo. 
Sedative tolerance to diazepam requires activation of specific GABAAR and is not the effect 
of general enhanced inhibition through all GABAAR subtypes. It is likely caused by 
adaptive mechanisms specifically activated by concurrent enhanced GABAergic inhibition 
of both α1- and α5-GABAAR.  
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1 Introduction 
 
γ -Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous 
system.  Its synaptic action is mediated mostly by GABAA receptors (GABAAR), which 
belong to the superfamily of ligand-gated ion-channels. This receptor is a heteropentameric 
complex assembled from a family of at least 21 subunit genes (α1-6, β1-4, γ1-4, δ, ε, θ, π, 
ρ1-3). This heterogeneity results in a wide range of GABAA receptor subtypes in the brain, 
with a functional GABAA receptor typically consisting of 2α, 2β and 1γ subunit. The 
different α subunits have their own subtype-specific localisation in the brain, with the α1 
subunit largely expressed in the cerebral cortex and the α2 subunit mainly in hippocampus 
and striatum (for detailed review: Fritschy and Brunig, 2003). The pharmacological 
properties of receptor subtypes are determined by their subunit composition. GABAA 
receptors containing an α1, α2, α3 or α5 subunit have a high affinity for classical 
benzodiazepines such as diazepam, whereas receptors containing an α4 or α6 subunit are 
diazepam-insensitive. Benzodiazepines are allosteric modulators of the GABAAR and they 
are widely prescribed for their sedative, anxiolytic, muscle-relaxant and anti-epileptic 
actions. Recent research has shown that different subtypes of GABAAR mediate 
benzodiazepine actions. In mice carrying an histidine to arginine point mutation in the α1-
subunit (α1H101R), the diazepam binding to the α1 GABAAR was abolished, together with 
the sedative action of diazepam (Rudolph et al., 1999). Mice with a similar point-mutation 
in other α-subunits revealed that diazepam’s anxiolytic effect is mediated by the α2-
GABAAR, and that the muscle-relaxant effect is partially regulated through α2- and α3-
subunits (Löw et al., 2000). These findings open new prospects for therapy, with subtype-
specific ligands devoid of side effects. Chronic treatment, however, often results in the 
development of tolerance, limiting the long-term use of benzodiazepines. The molecular 
mechanism of tolerance to benzodiazepines is as yet unknown. The subunit specificity for 
the actions of benzodiazepines raises the question whether the development of tolerance is 
mediated by specific GABAAR subtypes. A second possibility that has emerged is the view 
that tolerance to benzodiazepines stems from receptor internalisation (Tehrani and Barnes, 
1997; Ali and Olsen, 2001). Research over the past years has revealed that synapses are not 
stationary connection points between neurons, but highly dynamic sites. The amount of 
receptors in the synaptic membrane is subjected to change, depending on the rates of 
synthesis, insertion, lateral mobility, endocytosis and subsequent degradation or recycling 
(Figure 1). This plasticity requires that postsynaptic components can be quickly inserted or 
removed from the postsynaptic density (PSD). The dynamic regulation of surface receptors 
is one mechanism  
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Fig 1.: Processes involved in regulation of membrane receptors 
 
involved in phenomena such as long-term potentiation (LTP) and long-term depression  
(LTD). 
There is evidence that various (chronic) drug treatments might not result in mRNA or 
protein expression changes, but may rather affect the receptor cycle mentioned above, 
influencing the (sub)cellular distribution of synaptic proteins and receptors (Tehrani and 
Barnes, 1997; Ali and Olsen, 2001; Kumar et al., 2003; review Thomas and Malenka, 
2003), opening the possibility that tolerance is due to impaired receptor trafficking to the 
synapse. While relatively little is known about the molecular mechanisms of GABAAR 
trafficking, the regulation of AMPA receptors (AMPA R), which mediate excitatory 
neurotransmission, has already been extensively studied. The insertion and removal of 
AMPA R and GABAAR seem to be governed largely by the same protein kinases and 
protein phosphatases. Therefore the mechanisms involved in AMPA R regulation could 
give some insight into trafficking of the GABAA R. Below I will summarise current 
knowledge on trafficking, membrane stability and endocytosis of both receptor types and, 
with regard to the problem of benzodiazepine tolerance, the effects of (chronic) drug 
exposure on their surface expression will be compared. 
 
1.1 AMPA receptors 
 
The postsynaptic density (PSD) of glutamatergic synapses contains a large diversity of 
neurotransmitter receptors, signalling molecules and scaffolding proteins (review Kennedy, 
1997, see also Fig.2 on page 8).  It has one or more of the following glutamate receptors: 
NMDA R, AMPA R and kainate receptors. The central component of the glutamatergic 
PSD is the scaffolding protein PSD-95 through which the glutamate receptors are clustered 
at the synapse. This protein has several PDZ (PSD-95, Dlg, ZO-1- homology) domains, 
which are modular protein domains that can interact with C-terminal domains of other 
proteins. It is believed that perhaps several hundreds of proteins are brought in close 
vicinity of each other in the PSD through interactions with PDZ-domains of PSD-95 and 
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other proteins (Sheng, 2001; Sheng and Kim, 2002). AMPA R are linked to PSD-95 via a 
family of transmembrane AMPA R regulatory proteins (TARPs), among them a protein 
called stargazin (Bredt and Nicoll, 2003; Tomita et al., 2004).  
 
AMPA R are glutamate-gated channels that mediate a large part of excitatory transmission 
in the brain. Upon glutamate binding, the channel opens, allowing Na+ influx into the 
neuron. AMPA R consist of a combination of the subunits GluR1-4, possibly in a tetrameric 
conformation. The permeability of the receptor for calcium is determined by the presence of 
a glutamine in transmembrane region 2. The GluR2 subunit contains an arginine instead of 
glutamine, making the receptor impermeable for Ca2+. Through RNA editing, a process in 
which adenosine is converted into inosine, the glutamine codon (CAG) is changed into an 
arginine codon (CGG) (Sommer et al., 1991). As in vivo the prevalent heteromers are either 
build up from GluR1/2 or GluR2/3 subunits, the majority of AMPA receptors is Ca2+ 
impermeable. The GluR4 subunit is only expressed during development and can replace the 
GluR1 subunit in GluR1/2 heteromers. The GluR1 and the GluR4 subunits have a long 
cytoplasmic C-tail, whereas GluR2 and GluR3 subunits have a short one. This intracellular 
tail contains several sequences for interaction with proteins involved in trafficking, 
anchoring or phosphorylation of AMPA R. The longer C-tail of GluR1 and GluR4 harbours 
extra domains, leading to differences in transport, insertion and removal from the membrane 
compared to the GluR2 and GluR3 subunits (Shi et al., 2001). GluR2/3 heteromers are 
responsible for basal synaptic transmission in the brain, which is severely reduced in 
GluR2/3 double knockout mice (Meng et al., 2003). On the other hand, AMPA R 
heteromers with a GluR1 subunit are incorporated in the synapse in response to synaptic 
activity leading to long-term potentiation (LTP) (Hayashi et al., 2000), which is absent in 
GluR1 knockout mice (Zamanillo et al., 1999).  In order to understand the regulation of 
AMPA R, the interactions of the GluR1 and the GluR2 subunit with trafficking and 
stabilising proteins in the postsynaptic density have been studied extensively. 
 
1.1.1 Exocytosis & synaptic stability of AMPA receptors 
• GluR2 subunit 
GluR2/3 AMPA R heteromers cycle constitutively in and out of the synapse, evidence that 
they must be internalised and inserted constantly (Ehlers, 2000; Lin et al., 2000). Three of 
the proteins involved in exocytosis and synaptic stability will be highlighted below. One of 
the first proteins shown to bind to GluR2 was NSF (N-ethylmaleimide Sensitive Factor) 
(Nishimune et al., 1998), an ATP-ase known at that time to be involved in presynaptic 
exocytosis. Infusing a peptide that blocks the GluR2-NSF binding resulted in decreased 
surface expression (Noel et al., 1999) through increased endocytosis (Braithwaite et al., 
2002). Intriguingly, the NSF binding site partially overlaps with that of AP2, an adaptor 
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protein involved in clathrin-coated vesicle endocytosis (Lee et al., 2002). Loss of NSF-
binding would therefore free the GluR2 receptor for AP2 binding and consequent 
endocytosis. Binding to NSF apparently brings AMPA R containing the GluR2 subunit to 
the membrane and prevents their endocytosis.  
Another part of the intracellular domain of GluR2 interacts with GRIP/ABP protein 
(glutamate receptor interacting protein/ AMPA R binding protein). Different hypotheses 
circulate concerning the role of GRIP/ABP in AMPA R regulation. When the interaction 
with GRIP/ABP was disrupted by mutation of the GluR2 cytoplasmic tail, stable 
incorporation of this subunit into the membrane of cultured hippocampal neurons was 
prevented (Seidenman et al., 2003), review (Barry and Ziff, 2002). These imply that 
GRIP/ABP is involved in synaptic stabilisation of GluR2. This is in contrast with other 
reports that abolishing GRIP/ABP-GluR2 did not affect surface levels, only the amount of 
GluR2 that remained internalised after endocytosis (Braithwaite et al., 2002), (Fu et al., 
2003), suggesting that it interacts with the intracellular pool of GluR2. Since this PDZ 
protein is found in excitatory synaptic sites and in intracellular compartments (Burette et al., 
2001) both hypotheses could be correct. A third interacting PDZ protein is PICK-1 (Protein 
that Interacts with Kinase C), which, like PSD-95, is involved in clustering of AMPA R 
(Xia et al., 1999). By binding PKC, PICK-1 might also cluster PKC at synaptic sites where 
it can phosphorylate AMPA R, thus influencing their surface stability (see section on 
phosphorylation).  
 
• GluR1 
In contrast to the constitutive cycling of GluR2/3 heteromers, the longer C-tail retains the 
GluR1 subunits intracellularly and their insertion in the plasma membrane is activity-
dependent.  In hippocampal cell cultures and slices, neuronal activity causes an influx of 
Ca2+ that consequently results in coactivation of CamKII (Shi et al., 2001) and PKA, which 
in turn phosphorylates GluR1 in the Golgi (Ehlers, 2000; Esteban et al., 2003). The 
phosphorylation of the C-tail releases the retention and the GluR1 subunits are inserted into 
the synapse. The GluR4 subunit is more expressed than GluR1 in early development, and 
this subunit does not require the coactivation of CamKII for synaptic incorporation. The 
trafficking of GluR1 to the membrane depends also on interaction of the GluR1 subunit 
with the PDZ-protein SAP97, which binds to GluR1 subunits in the ER and Golgi. At the 
synapse, however, only a few AMPA R are found connected to this protein (Sans et al., 
2001). Mutation of the SAP97 binding site disrupts synaptic accumulation of GluR1 
subunits, another argument that SAP97 is important for delivery of the receptors to the 
synapse (Leonard et al., 1998). It must be stated that, although not so many interacting 
proteins are known for GluR1 as for GluR2, GluR1 is usually expressed as a GluR1/2 
heteromers and is therefore indirectly linked to the stabilising proteins that bind to GluR2.  
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1.1.2 Endocytosis of AMPA receptors 
• Phosphorylation 
Endocytosis of AMPA R is well studied and several components influencing the rate of 
internalisation are known. One important signal that determines whether a protein stays or is 
removed from the surface is its phosphorylation state. Phosphorylation can enhance or 
disrupt binding to interacting proteins and thereby affect cell surface stability and 
trafficking. AMPA R contain several consensus sites for phosphorylation by different 
protein kinases (See Table on page 17). In particular, the C-tail of the GluR1 subunit 
harbours phosphorylation sites for PKA and CamKII, whereas the GluR2 subunit can be 
phosphorylated by PKC. Synaptic incorporation of GluR1 involves phosphorylation at 
Ser845, which can be induced by agonist stimulation as mentioned previously; its removal 
by endocytosis is associated with dephosphorylation by the protein phosphatase calcineurin 
at this site (Ehlers, 2000; Esteban et al., 2003; Snyder et al., 2003). Also, agonist 
stimulation is known to redistribute GluR1 away from the synapse (Lin et al., 2000). 
Whether this effect results from-, or causes dephosphorylation of GluR1 is not yet clear, 
although recent evidence points to the latter: It has been shown that the GluR2 subunit is 
very mobile; it can move laterally within the membrane and is more stationary at synapses 
than extrasynaptically (Borgdorff and Choquet, 2002). As GluR2 is expressed at the cell-
surface as a heteromer, GluR1/2 or GluR2/3 heteromers can move out of the synapse and 
can be internalised perisynaptically, where hotspots of clathrin, a component of endocytic 
vesicles, are found (Blanpied et al., 2002). Furthermore, the protein phosphatase calcineurin 
can associate to these clathrin-coated vesicles via ampiphysin, a protein involved in 
clathrin-coated vesicle endocytosis. The calcium influx resulting from AMPA or NMDA 
receptor stimulation activates calcineurin. By its interaction with ampiphysin, calcineurin 
can possibly alter endocytosis rates (Lai et al., 1999; Beattie et al., 2000) and its close 
proximity to endocytosed GluR1 could lead to the dephosphorylation of Ser845 (Ehlers, 
2000; Snyder et al., 2003). 
For the GluR2 subunit, the effect of phosphorylation appears to be opposed to that of the 
GluR1 subunit; Phosphorylation at Ser880 at the cytoplasmic tail of GluR2 reduces the 
binding affinity of this subunit for GRIP/ABP, resulting in subsequent endocytosis 
(Matsuda et al., 2000; Seidenman et al., 2003). Binding of PICK-1 is not affected and it is 
believed that a second function of PICK-1 might be to prime the receptors for endocytosis 
(Chung et al., 2000; Seidenman et al., 2003).  
On the other hand, a recent study has shown that it might not be the phosphorylation that 
induces the endocytosis of GluR2, but the glutamate binding itself (Tomita et al., 2004). 
These authors demonstrated that binding of glutamate results in a conformational change of 
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the receptor that releases its connection with stargazin, freeing the AMPA R for 
endocytosis.  
The stimulus that leads to endocytosis also determines which endocytic pathway the 
receptor enters. Receptors that are endocytosed upon NMDA or AMPA stimulation enter a 
recycling endosome pathway, whereas insulin stimulation activates a calcium-independent 
pathway that results in the accumulation of receptors in an unknown, non-lysosomal, 
compartment (Beattie et al., 2000; Lin et al., 2000). 
 
• Ubiquitination 
Ubiquitination targets proteins to the proteasome, where they can be degraded (for review 
Hicke, 2001). Recent research points to a role of ubiquitination in AMPA receptor 
regulation. Blocking ubiquitination prevented agonist-induced (AMPA) endocytosis of 
GluR1 and GluR2 (Patrick et al., 2003). Whether ubiquitination of AMPA R plays a role in 
their endocytosis has not been investigated. However, another study demonstrated that 
ubiquitination of PSD-95 leads to reduction of PSD95 at synapses due to degradation by the 
proteasome and consequent reduction of AMPA R (Colledge et al., 2003). With fewer PSD-
95 available, fewer AMPA R can be clustered at the synapse, leading to reduced AMPA 
currents. 
 
1.1.3 AMPA receptor regulation in LTP and LTD 
 
The molecular cues and signals mentioned above come into play in AMPA R regulation and 
have been studied mainly in response to acute stimuli. As mentioned before, synaptic 
activity is needed for GluR1 containing AMPA R to be inserted in the membrane. In so-
called silent synapses (synapses that contain only NMDA receptors), NMDA R stimulation 
leads to de novo incorporation of GluR1/2 heteromers and ‘unsilencing’ of the synapse. In 
synapses that contain GluR2/3 heteromers, activation by either AMPA or NMDA results in 
a replacement of GluR2/3 heteromers by GluR1/2-containing receptors. Thus, the regulating 
subunit for constitutive cycling is the GluR2, and the dominant subunit for activity-
dependent insertion is GluR1 (Shi et al., 2001). 
AMPA R regulation is also studied extensively in hippocampal slices, as stimuli leading to 
the induction of long-term potentiation (LTP) or long-term depression (LTD) have a 
profound effect on the surface levels and the endo/exocytosis rates of AMPA R. LTP and 
LTD are considered as a molecular substrate of learning. For LTP, in short, a high 
frequency stimulation protocol leads to an increased synaptic strength that lasts for hours. 
For LTD, low frequency stimulation results in a decreased synaptic strength. Most of the 
studies described below investigated LTP and LTD in the CA1 region of the hippocampus, 
where both LTP and LTD are NMDA R dependent (Liu et al., 2004). The increase in 
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synaptic response seen with hippocampal LTP involves the GluR1 subunit: LTP is intact in 
GluR2/3 knockout mice (Meng et al., 2003) and is absent in GluR1 knockouts (Zamanillo et 
al., 1999). In the CA1 of the hippocampus, LTP is induced upon NMDA-R stimulation, 
which in turn activates CamKII that phosphorylates the GluR1 subunit at Ser 831 (Mammen 
et al., 1997). The effect on GluR1 seems to involve 2 mechanisms (review: Bredt and 
Nicoll, 2003): the first one involves a direct phosphorylation of AMPA R by CamKII, 
thereby facilitating the synaptic incorporation of this AMPA R. At the same time, GluR2/3 
heteromers are removed from the synapse, as phosphorylation by PKC leads to their 
endocytosis. The netto result is the replacement of GluR2/3 by GluR1/2 heteromers. There 
is a second mechanism necessary for the increased membrane expression of GluR1, since 
mutation of the Ser831 did not prevent the synaptic incorporation of GluR1 subunits. 
Possibly, an unknown protein is phosphorylated by CamKII and brings the AMPA R to the 
surface (Hayashi et al., 2000). One likely candidate would be SAP-97. 
While GluR1 incorporation is necessary for LTP, GluR2 endocytosis is essential for the 
induction of LTD. Transfecting cerebellar granule cell cultures that lacked GluR2 with a 
point mutated GluR2 subunit, which mimicked phosphorylation at Ser880, restored LTD 
(Chung et al., 2003). Thus, GluR2 phosphorylation and its subsequent internalisation are 
required for LTD induction. LTD not only involves increased GluR2 endocytosis, but PDZ 
proteins (e.g. GRIP/ABP) also bind to these internalised receptors and prevent their 
reinsertion in the plasma membrane (Daw et al., 2000). In conclusion, synaptic activity can 
influence interaction of AMPA R with trafficking or stabilising proteins by changing the 
phosphorylation state of the subunit. The differences on the molecular level between GluR1 
and GluR2 containing AMPA R, seen as a difference in the length of the C-tail, are 
reflected in the function that the different AMPA heteromers have, with GluR2/3 
heteromers responsible for basal transmission and GluR1/2 heteromers for LTP. 
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1.2 GABAA receptors 
 
GABAAR are ligand-gated ion channels mediating inhibitory neurotransmission in the 
brain. Upon GABA binding, the channel opens and the resulting chloride influx will cause a 
hyperpolarization and an increase in conductance, making it more difficult for the neuron to 
reach threshold for eliciting an action potential. The PSD of GABAergic synapses contain, 
in contrast to the glutamatergic PSD, far fewer identified proteins. In electron microscopy, 
the PSD of GABAergic synapses appears thinner and less electron dense than that of 
glutamatergic synapses. Studies in brain tissue and primary neuronal cultures have shown 
that GABAA R are localized postsynaptically, as they colocalize with gephyrin, a marker for 
the GABAergic postsynaptic density (Rao et al., 2000; Brunig et al., 2002a). GABAAR are 
synthesised in the ER and assembled into heteromers in the Golgi apparatus (Moss and 
Smart, 2001). In contrast to AMPA R, it is unclear what the exact molecular signals are that 
lead to the translocation of GABAAR from the Golgi to the postsynaptic density. It is 
probably independent of activity, since blocking synaptic activity has no effect on 
postsynaptic clustering of GABAAR (Craig et al., 1994; Studler et al., 2002). Nevertheless, 
some proteins that are involved the trafficking to the PSD and in the postsynaptic stability 
and clustering of GABAAR have been identified (see also Fig. 2). 
  
1.2.1 Synaptic incorporation and stabilisation of GABAA receptors 
 
Using a yeast-two-hybrid screen with the intracellular loop of the γ2 subunit as bait, a 17-kD 
protein has been identified that specifically interacts with the γ2-GABAAR subunit (for 
review: Kneussel, 2002). Though this GABAAR associated protein (GABARAP) can bind 
to the γ2 subunit, gephyrin and microtubules, it is not enriched at the synapse. Rather, 
GABARAP is found in intracellular compartments, such as the Golgi apparatus, and is most 
likely involved in trafficking the GABAAR to the synapse. The protein NSF, which is 
responsible for AMPA R stability at the synapse, can bind to GABA-RAP and helps 
bringing the vesicles with GABAAR to the membrane (Kneussel, 2002). Where exactly the 
GABAAR are inserted in the membrane remains to be elucidated. At the synapse, GABAAR 
form clusters that colocalize with gephyrin. This is thought to be a scaffolding molecule, as 
it can interact with itself and with microtubules and can thus create a lattice for proteins at 
the synapse. In contrast to PSD-95 in the glutamatergic synapse, gephyrin lacks PDZ-
domains. Although direct binding of gephyrin with the β subunit of the glycine receptor has 
been shown to trap and accumulate glycine receptors either intracellularly or at the 
membrane (Kirsch et al., 1995; Meier et al., 2001; Hanus et al., 2004), no direct interaction 
between gephyrin with GABAA R has ever been demonstrated (Kannenberg et al., 1997; 
Meyer et al., 2000). A functional interdependence of gephyrin and GABAAR has been 
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shown, though, in studies using knockout mice. Postsynaptic clustering of GABA R and 
gephyrin is impaired in γ2-/- mice, showing the role of the γ2 subunit in formation of these 
clusters. Gephyrin clusters are absent as well, illustrating that gephyrin needs the GABAAR 
to go to the synapse (Essrich et al., 1998). Abolishing γ2 subunit expression in the forebrain 
after brain maturation using Cre-CamKII mediated recombination resulted in a reduction of 
GABA R and gephyrin clusters, as well (Schweizer et al., 2003). This suggests that the γ2 
subunit is not only necessary for initiation of receptor clustering, but is also needed for 
maintaining these clusters. With fewer clustered receptors present, the gephyrin is also 
removed from the synapse, pointing towards a dynamic regulation of gephyrin. Results 
from gephyrin-/- mice are less conclusive: In one study it was demonstrated that GABAA 
receptor clustering is largely absent in gephyrin-/- mice  (Kneussel et al., 1999). However, a 
recent report showed that GABAAR clusters are present in cultured gephyrin-/- hippocampal 
neurons (Levi et al., 2004). This could reflect improvement of culture conditions, in which 
GABAAR can cluster at postsynaptic sites in a gephyrin-independent way.   
Another protein found clustered at the synapse is dystrophin, a member of the dystrophin-
associated protein complex (DPC). In mdx mice, which lack dystrophin, a strong reduction 
of GABAAR receptor clusters was detected, although gephyrin clustering was unaffected, 
showing that it is able to stabilise GABAAR at the synapse (Knuesel et al., 1999). However, 
in dystroglycan-deficient neurons that lacked dystrophin immunoreactivity, GABAAR 
clustering was intact (Levi et al., 2002). A hypothesis is that the DPC could provide a 
scaffold at the PSD, enabling changes in postsynaptic GABAAR number without loosing the 
postsynaptic apparatus (Fritschy and Brunig, 2003). Whether other proteins of the DPC are 
involved in GABAAR clustering still remains to be investigated. 
A further, recently discovered GABAAR interacting protein, Plic-1, is an ubiquitin-like 
protein that can bind to α and β subunit isoforms and is localised in both synapses and 
intracellular compartments. By binding to the GABAAR Plic-1 prevents degradation of 
GABAAR by the proteasome. Half-life times and number of surface GABAAR increased 
when Plic-1 was coexpressed with GABAAR in HEK293 cells. It is thus thought that Plic-1 
facilitates insertion of GABAAR in the membrane through stabilising the intracellular pool 
by preventing their degradation after endocytosis (Bedford et al., 2001). 
 
 
1.2.2 Endocytosis of GABAAR 
• Phosphorylation 
It is believed that phosphorylation of GABAAR subunits can influence surface receptor 
numbers in a similar manner as seen with AMPA R (review Kittler and Moss, 2003).  
Several phosphorylation sites were identified on GABAAR subunits that are targets for PKA 
and PKC (see table on page 17). The Ser 409 site of the β1 and Ser 408/409 of the β3 
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subunit are a major substrate for PKA, whereas β2 does not contain any PKA-sites. PKA is 
targeted to the GABAAR by A-Kinase Anchoring Proteins (AKAPs). AKAP is a PKA 
adaptor protein that selectively interacts with β1 and β3 but not β2 subunits (Brandon et al., 
2003).  
PKC can phosphorylate the β- and γ-subunits (Ser 409 for β1, Ser410 for β2, Ser 408/409 
for β3 and at Tyr365/367 for γ2), but not α subunits (Krishek et al., 1994; Connolly et al., 
1999; Brandon et al., 2002a).  PKC is directly associated to the β1 subunit intracellular loop 
from residue 405-415 and can then phosphorylate the corresponding residues. This is 
enhanced by the Receptor for Activated C-kinase (RACK-1), which binds to GABAAR β1 
subunits directly upstream of PKC. Although RACK-1 is not necessary for PKC binding to 
GABAA R, it does increase the amount of phosphorylation at Ser409 (Brandon et al., 
2002b). Inhibiting RACK-binding also decreases functional modulation by muscarinic M1 
G-protein coupled receptors that activate PKC. Thus it seems that RACK-1 has a 
comparable role as PICK-1 for AMPA R in controlling the amount of phosphorylation of 
GABAAR. 
 
Although progress has been made in identifying GABAAR substrates for protein kinases, 
how they affect receptor surface numbers of the GABAAR is not clear-cut. The effects of 
PKA depend critically on the phosphorylated residues and subunits: Phosphorylation of Ser 
409 of β1 in α1β1γ2 recombinant receptors resulted in a decreased GABA-response, 
whereas phosphorylation of both Ser408 and 409 in β3-containing receptors lead to 
potentiation of the GABA response (McDonald et al., 1998). Mutating Ser408 into an 
alanine in the β3-subunit converted the potentiation in an inhibition, mimicking the results 
seen with β1-subunits. In another study, inhibition of PKA decreased surface α1β2γ2-
GABAAR levels in transfected Sf9 cells (Ali and Olsen, 2001). This is interesting, since 
none of these subunits contains any PKA-phosphorylation sites, implying that another 
protein must play a role in this mechanism. In recombinant systems, phosphorylation of 
β2/3 by PKC (Krishek et al., 1994; Filippova et al., 2000; Brandon et al., 2002a) resulted in 
reduced GABA currents due to increased endocytosis of the GABAAR subunits. In neurons, 
the β3-subunit is constitutively phosphorylated at Ser408/409 and this could therefore be 
important for constitutive regulation of receptors in the synaptic membrane. In superior 
cervical ganglion neuron cultures, PKC activation resulted in increased endocytosis of β1 
containing GABAAR (Brandon et al., 2002b), which is similar to the effect of PKA on β1 
subunits mentioned above.  
Whether phosphorylation of the GABAAR always results in significant endocytosis in 
neurons is unclear: Evidence from α1β2γ2 transfected HEK293 cells suggests that PKC 
does not affect endocytosis itself, but blocks receptors from returning to the surface. This 
downregulation of receptors from the surface seems to be independent from PKC 
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phosphorylation of the γ subunit, as mutation of these PKC sites had no effect (Connolly et 
al., 1999). Data from studies with PKA also suggest that GABAAR dynamics mediated by 
PKA are also not necessarily regulated through phosphorylation of the receptor itself (Ali 
and Olsen, 2001; Lilly et al., 2003). Perhaps another protein that is involved in surface 
stability is affected by PKA and PKC, resulting in loss of surface receptors. Another 
hypothesis is that phosphorylation influences channel desensitization rather than surface 
localization (Hinkle and Macdonald, 2003; Jovanovic et al., 2004), as PKC activation did 
not change receptor surface numbers in cultured cortical neurons (Brandon et al., 2000). 
More research is therefore needed to elucidate the exact role that phosphorylation plays in 
GABAAR dynamics in neurons. 
 
1.2.3 Dynamic regulation of GABAAR 
 
Endocytosis of GABAAR has been studied in response to BDNF. BDNF is a growth factor 
that can act via the TrkB or p75 receptor. Application of BDNF on hippocampal neurons 
lead to a reduction of mIPSCs within minutes and this effect lasted for several hours 
(Brunig et al., 2001). This decrease was accompanied by a diminution of GABAR surface 
labelling. In contrast, Jovanovic et al (Jovanovic et al., 2004) showed a biphasic effect of 
BDNF on mIPSCs: an increase was detected in the first minutes, followed by a decrease as 
seen by Brünig et al. The biphasic effect was mirrored in the phosphorylation state of the 
β3-subunit: phosphorylation directly after BDNF exposure was mediated by PKC /RACK, 
whereas PP2A was responsible for dephosphorylation at the time when the decrease in 
mIPSCs was detected. However, no biphasic effect was seen on GABAAR surface levels.  
In cortical neurons the phosphorylation of β3-subunits of GABAAR and the associated 
reduction of GABA currents can be induced through muscarinic achetylcholine receptors 
via a G-protein coupled mechanism that activates PKC (Brandon et al., 2000). Furthermore, 
RACK-1 is implicated in the PKC-dependent regulation via 5-HT2 R (Feng et al., 2001).  
Dopamine receptors (DR) can play a role as well. Dopamine agonists reduced GABA 
currents in neostriatal neurons (Flores-Hernandez et al., 2000) and D4R in prefrontal cortex 
inhibited GABAAR function (Wang et al., 2002). First indications are that dopamine 
receptors do this via a PKA/PP1 signalling pathway for both AMPA R and GABAA R 
(Wang et al., 2002; Wolf et al., 2003). 
 
The regulation of GABAAR through phosphorylation appears more complex than that of 
AMPA R. The opposite effect of phosphorylation on the GABA response with the β1 or the 
β3 subunits in recombinant systems leaves room for differential modulation of GABAergic 
transmission in several brain regions depending on the expression patterns of these subunits. 
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1.3 Regulation of cell surface receptors by chronic drug use 
 
Synaptic activity can directly or indirectly regulate the amount of cell surface receptors in 
glutamatergic and GABAergic synapses. Acute and chronic administration of approved 
drugs or substances of abuse influences the synaptic activity in specific brain areas 
depending on their mode of actions. It is possible that changes in transmission will affect 
consequently the amount of receptors present in the postsynaptic membrane. Some of the 
effects that drugs have on AMPA R and GABAA receptor regulation will be discussed 
below. 
 
1.3.1 AMPA receptors 
 
Although AMPA R do not represent a pharmacological target in clinical use, chronic 
administration of drugs of abuse is associated with changes in AMPA receptor-mediated 
signalling and/or synaptic strength. Although most studies on LTP/LTD have focussed on 
the hippocampus or cerebellum, similar forms of potentiation also exist in the mesolimbic 
system, which plays an important role in the development of drug abuse and craving. 
Considerable evidence indicates that AMPA R mediate major down-stream effects of drugs 
activating the mesolimbic system. In the midbrain (ventral tegmental area) a single dose of 
cocaine resulted in increased synaptic strength due to an upregulation of number/function of 
AMPA receptors (Ungless et al., 2001). This seems to be true for several drugs of abuse 
with different mechanisms of action (review Thomas and Malenka, 2003). Another study 
demonstrated in nucleus accumbens cultures that stimulation of D1 receptors led to 
enhanced phosphorylation of GluR1 at the PKA site. This effect increased the GluR1 
surface expression levels accordingly, by changing the rate of externalisation (Chao et al., 
2002; Wolf et al., 2003). Moreover, local overexpression of GluR1 via injection of herpes 
simplex viral vector in the rostral VTA can enhance stimulant and rewarding properties of 
morphine (Carlezon et al., 1997).  It is intriguing to speculate that drugs of abuse might 
induce drug addiction by enhancing synaptic strength of glutamatergic synapses in the 
reward pathway via a dopamine-dependent mechanism. 
Other drugs also have effects on AMPA surface levels. Chronically treated hippocampal 
cultures with the antimanic agents lithium and valproate had reduced surface expression of 
GluR1, and synaptosomes of chronically treated rats also expressed less GluR1 (Du et al., 
2003).  In contrast, the antidepressants desipramine and paroxetine, selective noradrenaline 
and serotonin uptake inhibitors respectively, resulted in increased GluR1 and GluR2/3 in 
membranes of hippocampus, but not of cerebral cortex (Martinez-Turrillas et al., 2002). 
Several drugs might exert their actions by indirectly influencing glutamatergic synapses, 
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most likely through crosssignalling via PKA, PKC, or CamKII. This might provide a way 
for the development of adaptive mechanisms upon chronic drug treatment. 
1.3.2 GABAA receptors 
 
As mentioned in the beginning, a major class of drugs acting on the GABAAR is the 
benzodiazepines. They are positive allosteric modulators of GABA, thereby increasing the 
synaptic inhibition in the CNS. Tolerance to benzodiazepines develops readily after chronic 
use. Although the mechanism of tolerance is not known, the degree of tolerance and the 
time scale in which it is induced depends on the dose, the intrinsic activity of the ligand 
used, as well as its selectivity for certain GABAAR subtypes (Bateson, 2002). Tolerance to 
diazepam is for instance more readily induced when several low doses are given per day, 
thus keeping constant GABAAR occupation levels, then with a single high dose per day 
(Hutchinson et al., 1996b). Furthermore, ligands like zolpidem that are selective for the α1-
GABAAR have less tolerance liability than ligands that bind to all diazepam-sensitive 
receptors (Rush, 1998). Tolerance is not associated with major changes in GABAAR subunit 
expression and, in several experimental paradigms, is readily reversible with a single dose 
of the benzodiazepine antagonist flumazenil (Gonsalves and Gallager, 1988; Tietz et al., 
1999b). One of the possible causes of tolerance has been suggested to be the ‘uncoupling’ 
of the GABA-binding site and the benzodiazepine-binding site on the receptor. The lack of 
diazepam effect originates from the loss of the interaction between these two sites. 
Alternatively, a recent report suggested that tolerance to benzodiazepines might be due to 
induction of endocytosis of GABAAR.  In transfected sf9 cells the number of α1β2γ2 
GABAAR in the membrane decreased after chronic diazepam exposure and the main part of 
the receptors was detectable intracellularly. Another study demonstrated that after 7 days of 
lorazepam treatment, [3H]flunitrazepam-binding and α1 protein levels were increased in 
clathrin-coated vesicles and decreased in synaptosomes of mice (Tehrani and Barnes, 1997). 
The observation that receptors can be internalised after chronic diazepam exposure is 
consistent with the uncoupling-hypothesis. Diazepam is cell-permeable and can bind to 
internalised GABAAR whereas GABA cannot. Subsynaptic internal receptors might be 
quickly recruited back to the membrane surface after flumazenil exposure, resulting in 
‘recoupling’ since GABA and diazepam can now bind to the same receptor again. 
Internalisation of GABAA R after benzodiazepine exposure would also explain why clear 
changes in GABAAR expression and binding sites were not observed in several studies in 
tolerant animals (review Hutchinson et al., 1996a). Only long-term treatment with high 
doses of benzodiazepines seems to result in changes in expression levels. A recent model of 
tolerance states the following: initial potentiation of the GABA response is followed by 
desensitisation. This can be a cue for endocytosis, which results in the uncoupling of the 
GABA- and benzodiazepine site. In the long run, the endocytosed receptors could influence 
gene transcription, as seen in chronically treated animals (Bateson, 2002). The mechanism 
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of benzodiazepine-induced endocytosis is not resolved yet, although results from a 
heterologous expression system suggest that PKA inhibition might play a role (Ali and 
Olsen, 2001). In another study, a one-week flurazepam treatment in rats, known to result in 
anti-convulsant tolerance, decreased PKA activity and mIPSC amplitude in CA1 pyramidal 
cells (Lilly et al., 2003). How benzodiazepine exposure affects PKA activity remains to be 
investigated. Major unresolved issues, however, are whether all major GABAAR subtypes 
contribute to the development of tolerance to benzodiazepines, and whether the mechanisms 
of tolerance are the same for all benzodiazepine site ligands. In addition to benzodiazepines, 
chronic alcohol administration can induce internalisation of α1-GABAAR subtypes in rat 
cerebral cortex (Kumar et al., 2003). This effect was subunit specific and might be under the 
control of PKC, as the association of PKCγ with α1-GABAAR was reduced after chronic 
ethanol exposure (Kumar et al., 2002). 
 
1.3 Comparison of AMPA receptors versus GABAA receptors  
 
It is interesting to note that several treatment paradigms lead to opposite effects when 
comparing AMPA R with GABAAR (see table). First, protocols that induce LTP in 
glutamatergic synapses decrease the function of GABAergic synapses. NMDA R-dependent 
LTP of glutamatergic synapses in the CA1 region of the adult hippocampus involves a rise 
in calcium through the NMDA R, leading to LTD in GABAergic synapses (Stelzer and Shi, 
1994; review Gaiarsa et al., 2002). This LTD is accounted for by a reduction in GABAAR 
efficacy and is calcineurin dependent (Lu et al., 2000). Similarly, dendritic GABAAR 
activity in cerebellar granule cells is partially blocked by NMDA R via calcineurin 
dephosphorylation (Cupello and Robello, 2000). It is not clear, however, which GABAAR 
subunits calcineurin dephosphorylates and how this may lead to LTD. 
Insulin stimulates endocytosis of AMPA R (Beattie et al., 2000; Lin et al., 2000; Man et al., 
2003), whereas it increases β2 subunit-dependent exocytosis of GABAAR and enhances the 
amplitude of mIPSCs in HEK293 cells and cultured hippocampal neurons (Wan et al., 
1997). Even dopamine receptor stimulation produces different effects on the two receptor 
types, although studies were carried out in different types of preparations: application of a 
D1 agonist lead to increased GluR1 surface levels trough a PKA-dependent mechanism in 
nucleus accumbens cultures (Chao et al., 2002), whereas GABA currents were reduced in 
neostriatal neurons via a PKA/DARPP-32/PP1 pathway (Flores-Hernandez et al., 2000).  In 
general it can be said that both receptor types are regulated by similar signalling pathways, 
but with different end results. An open question is if these signalling pathways affect one or 
more synapse within the same cell, and how many synapses could be modulated at the same 
time.  
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The glutamatergic system is also affected by chronic diazepam use. Increases in NMDA R 
and AMPA R levels were reported after chronic benzodiazepine treatment and during the 
withdrawal phase (Tsuda et al., 1998; Izzo et al., 2001), and glutamate antagonist were able 
to prevent diazepam dependence (Steppuhn and Turski, 1993). The changes in these studies 
are related to the development of dependence and the withdrawal symptoms that occur after 
cessation of the treatment. However, it is conceivable that the glutamatergic system can 
contribute to the development of tolerance, as NMDA R subunit mRNA is upregulated after 
4 days of benzodiazepine exposure (Perez et al., 2003) All these observations imply that it 
will be essential in the future to investigate if or how inhibitory and excitatory synapses 
‘interact’ to changes induced by either stimuli or drugs. 
 
Conclusions 
The regulation of AMPA R and GABA R is very different: where AMPA R are directly 
influenced by synaptic activity, GABAAR are modulated through other types of receptors. 
We summarized here the most important of the many proteins and factors known to play a 
role in AMPA R trafficking. On the other hand, information on GABAAR regulation is only 
slowly emerging. GABAAR are a target for benzodiazepines, a class of drugs that is prone 
to the development of tolerance upon chronic administration. Changes in GABAAR 
regulation might underlie this phenomenon. It is therefore important to understand the basic 
trafficking of GABAAR in neurons and how benzodiazepines might affect this. 
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2 Aim of the thesis 
 
The number of GABAAR in the synapse determines the effectiveness of fast inhibitory 
neurotransmission. Changes in the amount of synaptic receptors numbers might underlie 
several patho-physiological states, as shown by an increase of GABAAR in the postsynaptic 
density in a kindling model of epilepsy (Nusser et al., 1998). It has been hypothesized that 
chronic diazepam might reduce the number of cell-surface receptors, thereby inducing 
tolerance. It also has to be taken into account that there are several GABAAR subtypes, 
which could be differentially affected by chronic diazepam treatment.  
Insight in the dynamic regulation of GABAAR will give us a better understanding how 
tolerance occurs. The aim of the thesis was thus to investigate normal regulation of GABAA 
R in cultured hippocampal cultures with fluorescence microscopy and in cortical neurons 
with biochemical methods. Secondly, using point-mutated mice available in the Institute, 
we analysed the role of different GABAA R subtypes in mice for the development of 
sedative tolerance after chronic diazepam or zolpidem treatment.  
 
Publication 1: Subsynaptic localisation of internalised GABAA receptors  (submitted to 
European Journal of Neuroscience) 
Endocytosis of GABAAR can be induced by factors such as BDNF (Brünig 2002), or by 
drugs like benzodiazepines (Tehrani & Barnes 2001, Ali & Olson 2001). Most of this work 
was done in heterologous expression systems or with biochemical methods. However, no 
reports are available so far for concerning the subcellular localization of GABAA R after 
endocytosis. We tagged the surface receptors in living cells with antibodies and observed 
the distribution and localization of surface and internalized tagged GABAAR in cultured 
hippocampal neurons using gephyrin as a GABAergic postsynaptic marker. We inhibited 
clathrin-coated vesicle endocytosis using various procedures to determine how GABAAR 
are internalized. The results obtained with high resolution fluorescence microscopy were 
verified in cultures of cortical neurons with a biotinylation assay on western blots. 
 
Publication 2: Requirement of α5-GABAA receptors for normal development of 
tolerance to the sedative action of diazepam (Journal of Neuroscience, 2004; 24(30): 
6785-90 ).  
A major class of drugs acting on GABAAR, the benzodiazepines, has as a drawback that 
tolerance to their actions can develop readily after chronic use. It is unclear what the 
molecular mechanisms behind this tolerance are. The general consensus is that no 
substantial changes in benzodiazepine binding sites occur. A question that is still open is 
whether all GABAAR participate in the development of tolerance. Specific neuronal 
circuits, containing different GABAAR subtypes, mediate the spectrum of action of 
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diazepam, suggesting that specific GABAAR subtypes could mediate the development of 
tolerance. To investigate the contribution of various GABAAR subtypes for the 
development of sedative tolerance, we used mice in which diazepam binding to specific 
GABAAR subtypes was eliminated by a point mutation. We assessed the motor depressing 
actions of a test dose of diazepam after an 8-day diazepam treatment schedule in wild type, 
α1(H101R), α2(H101R), α3(H126R) and α5(H101R) mice.  We also examined possible 
changes in the number of total benzodiazepine binding sites and of α5-specific binding sites 
in tolerant versus non-tolerant mice using autoradiography to determine whether chronic 
drug treatment alters the expression of functional GABAAR.  
 
Publication 3: Selective enhancement of α1-GABAA receptor activity by zolpidem is 
insufficient to induce full sedative tolerance and hippocampal α5-GABAAR 
downregulation  (in preparation). 
The development of sedative tolerance to diazepam appeared to depend on concurrent 
activation of α1- and α5-GABAAR. This would imply that compounds, such as zolpidem, 
that act only on α1-GABAAR subtypes would have a lower tolerance liability. Zolpidem 
has a high affinity for α1-GABAAR subtypes, an intermediate affinity for α2- and α3- 
GABAAR subtypes and a low affinity for α5-GABAAR subtypes. Due to this affinity 
pattern, chronic zolpidem is also able mimic the effect of diazepam seen in chronically 
diazepam-treated α5(H101R) mice. These mice did not display sedative tolerance, 
suggesting that the α1-GABAAR are still functional, however, we could not measure α5 
binding sites in these mice due to the point mutation.  
We wanted to confirm that specific enhancement of α1-mediated inhibition is insufficient 
for the development of sedative tolerance and the associated changes in α5-GABAAR 
binding sites. We assessed the motor depressant effect of zolpidem after chronic zolpidem 
administration and measured the number of α5-GABAAR binding sites in the hippocampus 
of these mice. Furthermore, we also tested whether α1-GABAAR are still 
pharmacologically, active by injecting a test dose of zolpidem after diazepam treatment. A 
time course of motor activity was also measured directly after the injection of the last dose 
to assess the duration of the sedative effect of zolpidem in chronically treated mice 
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3 Results 
 
3.1 Internalized GABA-receptor subunits are transferred to an 
intracellular pool associated with the postsynaptic density. 
 
Carolien van Rijnsoever, Corinne Sidler, Jean-Marc Fritschy 
 
European Journal of Neuroscience 2005; 21(2):327-38 
 
 
Abstract 
Endocytosis represents an important mechanism regulating cell-surface expression of 
neurotransmitter receptors, including GABAA receptors, in neurons. Little is known, 
however, about trafficking of internalized receptors. Here, we used antibody tagging in 
living hippocampal neurons in culture to monitor GABAA receptor internalization. We show 
that cell-surface receptors have a homogeneous distribution reflecting their mobility in the 
membrane. Unexpectedly, internalized GABAA receptors were detected in a subsynaptic 
pool associated with gephyrin at postsynaptic sites, whereas AMPA-receptors were 
accumulated in the soma. This process was time-dependent and could be prevented by 
blocking clathrin-coated vesicle endocytosis. In control experiments, the existence of an 
intracellular pool of GABAA receptors associated with gephyrin was confirmed 
independently of internalization of surface receptors, and constitutive endocytosis could be 
demonstrated for both AMPA- and GABAA receptors using a biotinylation assay. These 
results suggest that cycling of GABAA receptors between the cell surface and the 
subsynaptic pool provides a mechanism for short-term regulation of GABAergic 
neurotransmission. 
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Introduction  
GABAA receptors (GABAAR) are ligand-gated ion-channels that mediate the major part of 
inhibitory neurotransmission in the brain and are a target for several classes of drugs, such 
as barbiturates and benzodiazepines (Fritschy and Brunig, 2003). A functional receptor 
generally consists of a pentameric complex containing 2α, 2β and 1γ subunit selected from 
a repertoire of multiple variants (α1-6, β1-4, γ1-4) (Barnard et al., 1998). Most GABAAR 
that are clustered at postsynaptic sites contain the γ2 subunit and are colocalized with 
gephyrin, a cytoplasmic protein interacting with the cytoskeleton (Sassoe-Pognetto et al., 
2000; Luscher and Keller, 2004). The amount of GABAAR present in the postsynaptic 
density is cell type-dependent and correlates directly with synaptic strength, as shown under 
normal conditions (Nusser et al., 1997) and in a model of temporal lobe epilepsy (Nusser et 
al., 1998). Cell-surface expression and synaptic trafficking of GABAAR are regulated by 
phosphorylation mechanisms (Connolly et al., 1999a) and by factors such as BDNF (Brunig 
et al., 2001; Jovanovic et al., 2004) and insulin (Wan et al., 1997), which activate tyrosine 
kinase receptor-dependent signaling pathways. 
In a recombinant expression system, cell-surface expression of GABAAR was reduced upon 
chronic diazepam exposure, an effect due to increased endocytosis and dependent on PKA 
activation (Ali and Olsen, 2001). In vivo, GABAAR endocytosis likewise is enhanced 
following chronic ethanol (Kumar et al., 2003) or chronic flurazepam treatment (Tehrani 
and Barnes, 1997). Constitutive endocytosis mediated by clathrin-coated vesicles has been 
proposed as a mechanism regulating cell-surface expression of GABAAR.  It was first 
demonstrated in HEK cells transfected with α1β2γ2 subunit cDNAs (Connolly et al., 
1999b). In this assay, GABAAR were detected on the surface as well as in a perinuclear 
compartment and were shown to shuttle between the two pools. Additional evidence was 
provided by  Herring et al. (2003), who demonstrated that the clathrin adaptor-protein AP-2 
can associate with the β-subunit and disruption of this interaction results in an increased 
response to application of GABA. Likewise, overexpression of a dominant-negative form of 
dynamin prevents GABAAR internalization (Herring et al., 2003). Similar mechanisms are 
also operative in neurons (Kittler et al., 2000), as demonstrated by blocking the ampiphysin-
dynamin interaction with an inhibiting peptide.   
Data from transfected Xenopus oocytes also suggested that GABAAR present in an 
intracellular compartment could be delivered back to the surface (Filippova et al., 2000). On 
the other hand, modulation by PKC seems to prevent internalized receptors from returning 
to the surface (Connolly et al., 1999a). Association of internalized GABAAR with the 
ubiquitin-like protein Plic-1 was suggested to prevent their degradation by the proteasome 
(Bedford et al., 2001). Plic-1 might therefore stabilize the intracellular pool of receptors and 
facilitate their reinsertion into the membrane.  
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Although several mechanisms involved in GABAAR endocytosis have been characterized, 
little is known about the localization and fate of internalized GABAAR, in particular in 
dendrites. The aim of the present study was to monitor internalized GABAAR with 
immunocytochemical methods in primary hippocampal cell cultures, using antibodies to tag 
cell surface receptors. The results show that most internalized GABAAR are relocated to a 
subsynaptic pool associated with gephyrin at postsynaptic sites, suggesting a novel 
mechanism for short-term regulation of GABAergic synaptic function by rapid exchange of 
cell-surface receptors.  
 
Material & Methods 
Animals. Rat embryos were obtained from time-pregnant Wistar rats (Harlan, Horst, the 
Netherlands). All experiments were approved by the cantonal veterinary office of Zurich. 
Reagents. All reagents were from Fluka (Buchs, Switzerland) unless stated otherwise. The 
dynamin-inhibiting peptide (Shupliakov et al., 1997) QVOSRNPNRAP (non-permeable) 
and Myr-QVOSRNPNRAP (membrane permeable) were from Eurogentech (Seraing, 
Belgium). Sulfo-NHS-SS-biotin and Ultralink Immobilized Neutravidin biotin-binding 
protein were from Pierce (Rockford, IL). Buffer A was a 25mM Hepes buffer supplemented 
with 30 mM glucose, 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 1 µM glycine 
and 500 nM TTX (modified from Archibald et al., 1998). The solubilization buffer 
contained 0.5% deoxycholate, 1% NP40, 0.1% SDS, 150 mM NaCl, 50 mM Tris, 2 mM 
EGTA, 1 mM EDTA, 0.02% NaN3, 10 µg/ml leupeptin, 1 ml/l aprotinin, 0.1 mM PMSF. 
Cell culture. Primary cultures of E18 hippocampal neurons and E19 cortical neurons were 
prepared as described previously (Brunig et al., 2002b). Hippocampus or cerebral cortex 
was dissected on ice and incubated for 15 min at 37°C in PBS, pH 7.4, containing 1 mg/ml 
BSA, 10 mM glucose, 0.5 mg/ml papain (Sigma, St. Louis, MO) and 10 µg/ml DNAse-1 
(Sigma). Neurons were then dissociated by gentle trituration with a fire-polished Pasteur 
Pipette and suspended in DMEM (Gibcom, Invitrogen, Carlsbad, CA) containing 10% fetal 
calf serum (Invitrogen, San Diego, CA). The hippocampal neurons were plated at a density 
of 15’000 cells/cm2 and the cortical neurons at a density of 2.5*106cells per Petri dish (60 
mm). The medium was exchanged after 1 day with a defined, serum-free medium (Brewer 
and Cotman, 1989), and coverslips with glial cells, prepared from P0 rat cortex, were placed 
on top of the hippocampal cultures. No glia were added to the cortex cultures. Cultures were 
kept in a humidified incubator at 37° and 10% CO2 and were used after 2-3 weeks. 
Antibodies. Distinct subtypes of GABAAR were visualized by immunofluorescence staining 
using subunit-specific antibodies raised in our laboratory against N-terminal epitopes (α1, 
α2, γ2).  These antibodies have been characterized extensively (Fritschy et al., 1992; 
Fritschy and Mohler, 1995; Nusser et al., 1996). In addition, the monoclonal antibody bd-
17, recognizing both the β2 and β3 subunits, was used (Ewert et al., 1990).  The 
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monoclonal antibody mAb7a against gephryin was supplied by Connex (Martinsried, 
Germany). Rabbit anti-GluR1 was from Chemicon (Temecula, CA). Mouse anti-GluR1 
against an extracellular epitope of GluR1 (mAb8E11, GSALRNPVN (GluR1-flop740-748) 
plus a partial epitope, QGLL (GluR1-flop757-760), (Tonnes et al., 1999)) was a kind gift of 
Prof. Peter Streit (Brain Research Institute, University of Zurich, Switzerland). 
Distinction of cell-surface and intracellular GABAA receptors. Cell-surface receptors were 
labeled by a brief incubation of living hippocampal cultures for 10 min at room temperature 
(RT) with a high concentration of rabbit antibody against the α1 subunit (1:400 in buffer A 
containing 0.5 M sucrose) and quickly rinsed. These conditions are non-permissive for 
internalization. The cultures were then fixed and permeabilized with methanol for 10 min at 
–20°C and rinsed with PBS. With this treatment, intracellular receptors became accessible 
to primary antibodies. The cultures were then incubated for 60 min at RT in a guinea pig 
anti-α1 subunit antiserum (diluted 1:4000 in PBS containing 10% FCS), washed three times 
with PBS, and incubated for 30 min in a mixture of goat anti-rabbit and goat anti-guinea pig 
secondary antibodies conjugated to Alexa 488 (Molecular Probes, Eugene, OR) and Cy3 
(Jackson Immunoresearch, West Grove, PA), respectively.  
Internalization protocol. Cell-surface receptors were tagged in living cultured neurons with 
primary antibodies against the α1, α2, or γ2 subunit. The tagged receptors were allowed to 
internalize at 37ºC, prior to fixation and permeabilization of the cultures and subsequent 
labeling of internalized receptors and intracellular markers, such as gephyrin. The 
experiments started by removing the medium and equilibrating the cultures in buffer A/0.5 
M sucrose to inhibit internalization. They were then incubated with guinea pig antisera 
against the α1 (1:400), α2 (1:100) or γ2 subunit (1:200) for 10 min at RT in buffer A/0.5 M 
sucrose to tag the cell-surface receptors. After washing with Buffer A/0.5M sucrose, the 
medium was returned to the cultures, which were placed back into the incubator at 37ºC for 
up to 60 min to allow internalization of the tagged GABAAR. The cells were then fixed for 
10 min under non-permeabilizing conditions (4% paraformaldehyde in 0.1 M phosphate 
buffer containing 4% sucrose). They were rinsed with PBS and incubated for 30 min with 
goat anti-guinea pig antibodies conjugated to Alexa488 to visualize the remaining surface 
receptors. After washing with PBS, cells were permeabilized with methanol at –20 °C for 
10 min and incubated with mAb7a against gephyrin (1:400) for 60 min. and washed again. 
Finally, the cultures were incubated for 30 min with a mixture of two secondary antibodies 
(goat anti-guinea pig conjugated to Cy3 to label the internalized receptors and goat anti-
mouse conjugated to Cy5 for gephyrin). After washing, cultures were dried and 
coverslipped.  In control experiments, the internalization of tagged receptors was prevented 
by incubating the cultures at 4ºC or with 0.5 M glucose. The involvement of clathrin-coated 
vesicles was assessed using a membrane-permeable, myristoylated dynamin-inhibiting 
peptide (Shupliakov et al., 1997) and the non-myristoylated control peptide, which were 
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added to the medium 30 min before antibody labeling (50 µM in PBS). The same medium 
with peptide was applied for the internalization. 
For comparison with GABAAR, the internalization of AMPA receptors containing the 
GluR1 subunit was visualized with a similar protocol, using a monoclonal antibody raised 
against an extracellular epitope. The medium was supplemented with 100 µm AMPA to 
enhance the rate of internalization (Beattie et al., 2000). 
Biotinylation assay. Biotinylation assays were performed as described previously (Mammen 
et al., 1997) to assess internalization of GABAAR independently of antibody tagging. 
Leupeptin (10 µg/ml), a lysosomal inhibitor, and/or the myristoylated dynamin inhibiting 
peptide (50 µM) were added to the medium 30 min before the start of the experiment. The 
cerebral cortex cultures were placed on ice and biotinylated with ice-cold Sulfo-NHS-SS-
biotin (0.5 mg/ml in Buffer A) for 12 min and washed with ice-cold buffer A. Cultures for 
the total surface and background measurement were left on ice, and other cultures were 
returned to the incubator for 30 min. In all samples except the ‘total surface’, biotin was 
cleaved with a gluthathione solution (75 mM gluthathione, 75 mM NaCl, 10 mM EDTA, 
1% BSA, pH 8.0) for 2 x 15 min on ice. After solubilization, biotinylated proteins were 
precipitated using Neutravidin beads, eluted with sample buffer and resolved by SDS-
PAGE. Samples were immunoblotted with a rabbit antibody against the GluR1 subunit 
(1:4000) and GABAAR β2/3 subunits (monoclonal bd-17; 1:4000), followed by secondary 
antibodies conjugated to horseradish-peroxidase (1:5000) and subsequent signal detection 
with luminol/enhancer buffer (Bio-Rad Laboratories, Reinach Switzerland). 
Data analysis. Images from immunofluorescence staining were digitized with a high-
resolution digital camera (Hamamatsu Orca, Hamamatsu Photonics, Hamamatsu City, 
Japan) driven by the OpenLab imaging software (Improvision, Coventry, England). For 
quantitative analysis of staining intensity, images were acquired with a laser scanning 
confocal microscope (LSM 510 Meta, Carl Zeiss AG, Feldbach, Switzerland), using a 100x 
objective with a numerical aperture of 1.4 (voxel size, 0.18 µm). Image acquisition 
parameters were adjusted to the full dynamic range of the photodetector and all images from 
a particular experiment were taken with the same settings. Cells to be imaged were chosen 
on their overall appearance and contained average densities of gephyrin clusters. Per cell 
culture, at least 10 fields were sampled. Fluorescence signals were calibrated using 
fluorescent beads (Molecular Probes, Eugene, OR) of known relative intensity.  Gephyrin 
clusters were used as a mask to outline α2-GABAAR clusters, and the size and fluorescence 
intensity were integrated for all clusters in the field, using a threshold segmentation 
algorithm (MCID M5 software; Imaging Research, Ste-Catherines, ON). To be considered, 
clusters had to have a size of at least 3 pixels and 15% intensity above background 
(equaling an intensity of 5% on the calibration curve ranging from 0-35 %).  The data for 
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the dynamin inhibiting peptide quantification were collected from three independent 
experiments.   
Statistics. Results, expressed as mean ± SD, were analyzed using non-parametric Kruskall-
Wallis analysis and, whenever appropriate, Dunn’s Multiple comparison’s test for post-hoc 
mean comparisons. 
 
Results 
Identification of two distinct pools of GABAA receptors. 
To distinguish cell-surface receptors from intracellular receptors in untreated, mature 
hippocampal neurons in vitro, cells were labeled sequentially with a rabbit and a guinea pig 
antiserum against the α1 subunit before and after membrane permeabilization. Cell-surface 
receptors were labeled under conditions non-permissive for internalization to prevent their 
translocation into the cell prior to labeling the existing intracellular pool. Staining of 
gephyrin was used to mark the GABAergic postsynaptic densities (Brunig et al., 2002a). 
The analysis was performed in presumptive interneurons, which express an intense staining 
for the α1 subunit in cultures after 14-21 days-in-vitro DIV. As reported previously (Brunig 
et al., 2002a), most pyramidal cells in the same culture exhibited only a very weak staining 
for the α1 subunit (not shown).   
The staining of cell-surface α1-GABAAR in these interneurons was homogeneous on the 
soma and neurites (Fig. 1A, green), with little evidence for local aggregation in the form of 
clusters. Although co-localization with gephyrin-immunoreactivity (-IR) was evident (Fig. 
1, arrows), the distribution pattern of the α1 subunit could not be used to predict the 
localization of GABAergic synapses in these cells. Staining of the intracellular α1-
GABAAR with the guinea pig antibody (Fig. 1B, red) was detected in exactly the same 
cells. Most unexpectedly, the corresponding α1 subunit-IR exhibited a clustered pattern in 
neurites, and these clusters were colocalized extensively with gephyrin. Only a few 
intracellular receptor clusters did not appear to be localized at synaptic sites (Fig. 1, 
arrowhead). This observation implies that, although many α1- GABAAR are present in the 
membrane of interneurons, there is, in addition, an intracellular pool of GABAAR 
associated with gephyrin presumably at postsynaptic sites. Furthermore, this intracellular 
pool is present only in cells exhibiting a prominent surface staining. 
In control experiments, the rabbit antibodies bound to the surface receptors were saturated 
with unlabeled secondary antibodies prior to permeabilization and application of fluorescent 
anti-rabbit IgGs.  No staining was observed (not shown), confirming that internalization 
was blocked effectively.  Conversely, gephyrin staining was not detectable prior to fixation 
and permeabilization of the cells (not shown), indicating that membrane integrity was 
preserved during the tagging procedure. 
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 Fig. 1. Digital photomicrographs from epifluorescence microscopy illustrating the distinct distribution of cell-
surface (green) and internal (red) GABAAR in a cultured hippocampal neuron, as revealed by sequential 
labeling with α1 subunit antibodies raised in distinct species before and after membrane permeabilization. The 
surface receptors, detected with the rabbit antibody, exhibit a homogeneous distribution on dendrites, whereas 
the internal receptors (guinea pig antibody) are clustered at sites containing gephyrin (blue).  The boxed area is 
enlarged in the bottom row.  Arrows show the presence of cell surface α1 subunit staining at a presumptive 
postsynaptic site labeled with gephyrin.  A cluster of internal receptors is present at the same site, precisely 
colocalized with gephyrin.  Arrowheads point to a cluster of internal α1 subunit staining not associated with 
gephyrin.  Scale bar, 10 µm.  
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Internalized GABAA receptors replenish the intracellular pool 
We investigated the possibility that the intracellular pool of GABAAR associated with 
gephyrin originates from surface receptors by monitoring the distribution of internalized 
receptors that were previously tagged at the cell surface. Live cultures were incubated with 
primary antibodies, washed, and returned to the incubator for one hour to allow for 
constitutive (or antibody-induced) endocytosis. Cell-surface receptors were visualized with 
fluorescent secondary antibodies after fixation with 4% PFA/sucrose, whereas internalized 
receptors were detected subsequently, using a different fluorochrome, after permeabilization 
of the membrane. These experiments were performed with the α1 subunit in interneurons 
and with the α2 and γ2 subunit in principal cells after 14-21 DIV (Fig. 2). In interneurons, 
staining of surface α1-GABAAR was again homogeneously distributed and showed no 
enrichment at postsynaptic sites. In contrast, the receptors tagged at the surface and allowed 
to internalize formed clusters in neurites that were colocalized extensively with gephyrin 
with a characteristic synaptic pattern (Fig. 2A). Similar results were observed also for the 
α2- and γ2- subunit in presumptive pyramidal cells (Fig. 2B and C), with a diffuse 
distribution of cell surface receptors, and a clustered distribution of internalized receptors. 
The fact that brightly stained clusters co-localized with gephyrin become visible only after 
permeabilization of the membrane is harmonious with their intracellular localization. 
The appearance of the intracellular clusters was time-dependent and correlated with the 
duration of incubation at 37°C. At time zero, the Cy3-conjugated secondary antibody used 
to label internalized receptors apparently cross-reacted with the Alexa 488-conjugated 
antibody applied onto cell-surface receptors, resulting in a similar staining pattern (Fig. 3A).  
This cross-reactivity diminished gradually, as internalized receptors became visible after 20 
min at 37°C (Fig. 3B). The staining intensity of the intracellular clusters increased further 
with time (Fig. 3C-E) and after 30 min incubation, the cross-reactivity between the two 
secondary antibodies was negligible. These experiments were repeated in the presence of a 
GABA agonist (THIP, 150 µM), an antagonist (bicuculline, 40 µM), or an allosteric 
modulator (diazepam, 1 µM), but these treatments during the incubation did not affect the 
speed or extent of internalization, as assessed by the appearance and staining intensity of 
intracellular clusters (data not shown).  
These data indicate that α1-, α2- and γ2-GABAAR are internalized in a time-dependent 
manner and become localized in the subsynaptic pool associated with gephyrin, suggesting 
that this intracellular pool is replenished by GABAAR internalization.  To verify that these 
results are not an artifact of the staining procedure, similar experiments were performed for 
AMPA receptors, using an antibody against an extracellular epitope to tag cell surface 
receptors in living cells, and sequential detection of internalized receptors after 15 min 
incubation at 37°C in the presence of 100 µM AMPA. 
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 Fig. 2. Digital photomicrographs from epifluorescence microscopy demonstrating the distribution of 
GABAAR clusters (red) following internalization of surface receptors tagged with an antibody in living 
cultures maintained at 37ºC for 60 min.  Upon fixation, cell-surface receptors (green) appear uniformly 
distributed, whereas the internalized receptors (red), detected after membrane permeabilization, are distributed 
in clusters colocalized with gephyrin (blue). Merged images are shown in the panels on the right. A) 
Internalization of α1 subunit-containing GABAAR in a presumptive interneuron; B) Internalization of α2 
subunit-containing GABAAR in a pyramidal cell; the boxed area is enlarged below to illustrate the spatial 
relationship of the surface receptors and internalized receptors with gephyrin. C) Internalization of γ2 subunit-
containing GABAAR in a pyramidal cell. Scale bars: A-C, 10 µm. 
 
In these experiments, images were collected by confocal laser scanning microscopy to 
distinguish the surface and the interior of the cells. These experiments were directly 
compared to results obtained for the GABAAR α2 subunit.  In Fig. 4, two confocal planes 
across the same cell are shown for each antibody, depicting cell surface receptors in green 
and internalized receptors in red. At the two levels, internalized AMPA receptors 
accumulate within the cell body and dendrites within 15 min (Fig. 4A), without forming 
clusters at presumptive synaptic sites. In contrast, the internalized α2-GABAAR subunit was 
redistributed to clusters in dendrites, and was only moderately accumulated in the soma, as 
seen after 60 min of internalization (Fig. 4B). Therefore, the selective aggregation of 
internalized GABAAR in a pool associated with gephyrin appears to be a specific property 
of these receptors. 
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 Fig. 3. Time-dependency of the internalization of cell surface GABAAR tagged with an antibody against the 
α2 subunit in living cells incubated at 37ºC for 0 (A), 10 (B), 20 (C), and 30 min (D). Antibodies bound to cell 
surface receptors were saturated with an unlabeled secondary antibody prior to applying the fluorescent 
antibody to detect internalized receptors. Images were collected by confocal laser scanning microscopy and a 
single confocal layer, close to the bottom of the cells, is depicted in each panel. At t0 and t10, a diffuse 
staining is apparent with the fluorescent secondary antibody, but clusters appear gradually thereafter and 
become clearly discernable after 20 min (C) and are quite prominent after 30 min incubation (D). 
Quantification of the intensity of the intracellular α2 subunit fluorescence at post-synaptic sites at the different 
time-points is depicted in E. Scale bar, 10 µm.  
 
  
Blocking clathrin-coated vesicle-mediated endocytosis inhibits the internalization of 
GABAA receptors. 
The internalization of GABAAR noted above was time-dependent, but it was not affected by 
a GABA agonist or antagonist, raising the possibility that it was triggered by antibody 
binding.  Therefore, several experiments were performed to test whether constitutive 
internalization mediated by a clathrin-dependent mechanism occurs in pyramidal cells, 
using the α2 subunit staining. Hypertonic sucrose inhibits the formation of clathrin-coated 
vesicles by flattening the clathrin lattices (Heuser and Anderson, 1989) and can therefore be 
used to inhibit internalization. Alternatively, clathrin-coated vesicle-mediated endocytosis 
can be blocked by competitive blockade of the interaction between dynamin and 
ampiphysin, using a dynamin-interacting peptide (Shupliakov et al., 1997). Cultures that 
were incubated at 4°C for one hour did not show any clear clusters of internalized receptors 
(Fig. 5B) compared to control (Fig. 5A), providing the first evidence for an active 
biochemical process. The addition of hypertonic sucrose also inhibited the formation of 
intracellular clusters (Fig. 5C), to the same extent as seen in cultures that were kept at 4°C. 
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Fig. 4. Differential subcellular distribution of internalized AMPA receptors (GluR1 subunit) and GABAAR 
(α2 subunit) in cultured hippocampal cells, as illustrated by confocal laser scanning microscopy following 
labeling of cell-surface receptors (green) and internalized receptors (red) upon incubation at 37ºC for 15 and 
60 min, respectively. A single confocal image close to the bottom of the cell is depicted; the insets show a 
confocal plane higher up through the soma of the same cell. Staining for internalized GluR1 subunit is most 
prominent in the soma, whereas internalized α2 subunit-containing GABAAR mainly are present in clusters on 
dendrites and are much less prominent in the cell body.  Scale bars, 10 µm. 
 
Finally, when a membrane-permeable, myristoylated dynamin-inhibiting peptide was added 
to the medium 30 min prior to antibody tagging and during the internalization step, the 
staining intensity of internalized α2 subunit clusters was greatly reduced (Fig. 5E).  The 
non-membrane permeable form of the peptide (Fig. 5D) did not prevent the formation of 
internalized clusters. The staining intensity of the postsynaptic, internalized α2 clusters was 
quantified using fluorescent beads with standardized intensities for calibration. The 
myristoylated dynamin-inhibiting peptide effectively reduced the intensity of the 
postsynaptic clusters (71% of vehicle treated cultures) [H=25.80, P<0.001, Kruskal-Wallis]. 
The non-permeable form did not affect the staining intensity. Intriguingly, cultures treated 
with the myristoylated peptide also showed a marked reduction in intensity of gephyrin 
clusters (81% of vehicle treated cultures) [H=25.36, ** P<0.01 Kruskal-Wallis]. Thus, 
blocking clathrin-coated vesicle endocytosis can inhibit the formation of the intracellular 
clusters in this immunocytochemical assay. 
To determine whether GABAAR are constitutively internalized in mature, primary neuronal 
cultures, independently of antibody tagging, surface proteins were bound with a cleavable 
form of biotin. After incubation and subsequent endocytosis at 37°C, the biotin on cell-
surface proteins was cleaved with glutathione and the remaining biotinylated proteins were 
precipitated with Neutravidin beads, separated by gel electrophoresis, and GABAAR 
subunits identified by Western blotting. The constitutive internalization of the AMPA 
receptor GluR1 subunit was taken as a positive control. Under basal conditions, a prominent 
signal was observed for the endocytosed GluR1 subunit, whereas only a band of moderate 
intensity appeared for the GABAAR β2/3 subunits (Fig. 5G). Only the β3 subunit, which  
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 Fig.5. Inhibition of clathrin-coated vesicle formation prevents internalization of GABAAR and their 
appearance in intracellular clusters. A-C: Digital images from epifluorescence microscopy depicting cell-
surface intracellular α2-GABAAR in hippocampal pyramidal cells that were incubated for 60 min at 37° (A; 
control), at 4°C (B), or at 37° in medium with 0.5 M sucrose (C).  In the two latter conditions, no internalized 
receptors became apparent. Scale bar, 10 µm. D, E: Effect of 50 µM of a non-permeable (D) or membrane-
permeable, myristoylated form of a dynamin-inhibiting peptide (E) on the internalization of α2 subunit-
containing GABAAR tagged at the cell surface, as visualized by confocal laser scanning microscopy. 
Inhibition of the dynamin-ampiphysin interaction by the membrane-permeable peptide largely blocked the 
internalization of the tagged receptors. Scale bar, 10 µm. F: Quantification of the effect of the dynamin-
inhibiting peptide on the staining intensity of internalized α2 subunit clusters and gephyrin clusters. The 
myristoylated peptide reduced the intensity of both α2 subunit (*** P<0.001; Kruskal-Wallis) and gephyrin 
(** P<0.01; Kruskal-Wallis) clusters, whereas the non-permeable form had no effect. This experiment was 
replicated three times with 15-30 cells measured per treatment. G: The membrane-permeable form of the 
dynamin inhibiting peptide blocks endocytosis of AMPA receptors and GABAAR in a biotinylation assay. 
Surface proteins and internalized proteins were separated by SDS-PAGE and labeled by Western blotting 
using antibodies to the GluR1 subunit (upper band) and the monoclonal bd-17 (lower bands).  Lane 1: total 
surface; lane 2: background measured in cultures maintained at 4°C to prevent internalization; 3: internalized 
receptors following 30 min incubation at 37 °C, 4: internalized receptors following incubation for 30 min at 37 
°C in the presence of 50 mM myristoylated dynamin-inhibiting peptide. Note that the upper of the two bands 
detected by bd-17, which corresponds to the β3 subunit is more strongly internalized than the lower band (β2 
subunit). 
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was more abundant than the β2 subunit (upper band of the 50 kDa doublet in lane 1), was 
detectable inthe endocytosed sample (lane 3) following a short exposure of the film. The 
appearance of 
these bands could be blocked effectively in the presence of the membrane-permeable 
dynamin-inhibiting peptide (Fig. 5G, lane 4), providing direct evidence for constitutive 
endocytosis of both AMPA receptors and GABAAR in primary neuronal cultures of the 
cerebral cortex.  
 
Discussion 
The present results demonstrate the existence in mature neurons of an intracellular pool of 
GABAAR, which colocalize with gephyrin at presumptive postsynaptic sites. Cell-surface 
receptors tagged with antibodies in living cells have a rather homogeneous distribution on 
the soma and neurites and are constitutively internalized in clathrin-coated vesicles. After 
endocytosis, a large fraction of these receptors is transferred in the intracellular, subsynaptic 
pool of GABAAR. The constitutive cycling of GABAAR between the cell surface and this 
subsynaptic pool likely represents a novel mechanism for short-term regulation of 
GABAergic synaptic plasticity. 
Functional and ultrastructural studies provide unambiguous evidence that GABAAR are 
clustered postsynaptically opposite to GABAergic terminals (Somogyi 1998; Maccaferri et 
al., 2000; Bergersen et al., 2003). These receptors are associated with gephyrin, which is 
located selectively in the postsynaptic density of symmetric, inhibitory synapses (Giustetto 
et al., 1998; Sassoe-Pognetto et al., 2000). Extrasynaptic receptors are present at much 
lower density in the somatodendritic plasma membrane (Nusser et al., 1995). Owing to the 
narrowness of the synaptic cleft, postsynaptic GABAAR subunits are not readily accessible 
in fixed tissue to antibodies raised against extracellular epitopes. In electron microscopy, the 
problem has been circumvented by the use of post-embedding staining, where the synaptic 
cleft is exposed in ultrathin sections.  In light microscopy, postsynaptic GABAAR clusters 
can be detected in sections prepared from weakly fixed, fresh frozen tissue, in which the 
integrity of cell membranes is compromised (Fritschy et al., 1998; Sassoe-Pognetto et al., 
2000). The present results show that, in cultured hippocampal neurons, these postsynaptic 
clusters are not detected by immunofluorescence, unless the plasma membrane is 
permeabilized, indicating that a significant fraction of GABAAR at postsynaptic sites are 
not accessible to antibodies in intact cells. Therefore, GABAAR clusters seen in light 
microscopy, colocalized with gephyrin, most likely include also receptors located 
intracellulary. Labeling of cell-surface receptors revealed only minor differences in staining 
intensity between postsynaptic and extrasynaptic receptors. The reason for this discrepancy 
with ultrastructural studies is not known. Lateral movement of receptors diffusing from 
postsynaptic to extrasynaptic sites, as demonstrated for glycine and AMPA receptors 
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(Choquet and Triller, 2003), during the incubation with primary antibodies might account 
for this inconsistency, a process possibly amplified by “antibody capping”. Staining of cell-
surface AMPA receptors (Fig. 4) also failed to demonstrate the presence of clusters in 
dendrites, possibly for the same reason. 
A direct demonstration of the co-existence of the intracellular pool and surface receptors 
with a distinct distribution could be achieved in interneurons, using two antibodies raised in 
different species against the α1 subunit. It is very likely that the same compartmentalization 
also exists for α2-GABAAR in pyramidal cells, in view of the similarity of the distribution 
of internalized receptors in both cell types.  Furthermore, the experiments with the γ2 
subunit, which is present in most GABAAR subtypes, strongly suggest that heteromeric 
complexes are translocated from the cell surface to the subsynaptic pool.  This translocation 
most likely occurs via endocytosis, since it could be blocked by procedures known to 
interfere with internalization mediated by clathrin-coated vesicles (low temperature, 
hyperosmolarity, blockade of ampiphysin-dynamin interaction).  Although the level of 
constitutive internalization of GABAAR seems to be less than AMPA receptors (Figs. 4-5), 
this translocation is sufficiently rapid to allow the detection of clustered, internalized 
receptors within about 20 min. It is therefore a major finding of the present study that 
constitutive endocytosis of GABAAR apparently serves to replenish the subsynaptic pool of 
GABAAR.  Furthermore, this observation might explain why, in other studies, cell-surface 
GABAAR labeled in living cultures at room temperature (for example, Brunig et al., 2002a; 
Levi et al., 2004) apparently were clustered at postsynaptic sites.  
This phenomenon is specific for GABAAR, since internalized AMPA receptors tagged with 
an antibody were not redirected to presumptive postsynaptic sites, but accumulated within 
the cell body. The difference is the more striking, as internalization is blocked in both cases 
by interference with clathrin-coated vesicle formation (Carroll et al., 1999b; Man et al., 
2000). The fate and intracellular sorting of internalized receptors are therefore distinct for 
AMPA receptors and GABAAR. A second difference stems from our observation that the 
internalization rate of tagged GABAAR was not influenced by exposure to THIP, 
bicuculline, or diazepam, whereas agonist exposure is well known to induce internalization 
of AMPA receptors (Carroll et al., 1999a; Beattie et al., 2000; Ehlers, 2000). A recent study 
has shown, however, that enhancing network activity in hippocampal slices leads to 
increased internalization of GABAAR (Blair et al., 2004). It is therefore possible that 
neuronal activity indirectly influences GABAAR internalization by activating signal 
transduction pathways controlled by G-protein-coupled receptors or tyrosine kinase 
receptors. This hypothesis is in line with the demonstration that several types of 
metabotropic receptors, including muscarinic acetylcholine receptors (Brandon et al., 2002), 
dopamine receptors (Flores-Hernandez et al., 2000), and 5-HT receptors (Huidobro-Toro et 
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al., 1996; Feng et al., 2001), modulate phosphorylation mechanisms that regulate the 
internalization of GABAAR. 
Little is known about intracellular trafficking of GABAAR following synthesis or 
internalization. A first major question raised by the present results concerns the trafficking 
of internalized GABAAR, likely found in vesicles, towards the subsynaptic compartment. 
Among the GABAAR-interacting factors, brefeldin A-inhibited GDP/GFP exchange factor 2 
(BIG2), which binds to the cytoplasmic loop of β subunit variants, has been located in 
vesicles in synapses and in the dendritic cytoplasm, sometimes co-localized with GABAAR 
(Charych et al., 2004). BIG2 is homologous to proteins involved in vesicular trafficking and 
might therefore contribute to redirect internalized GABAAR to subsynaptic sites or regulate 
their cell-surface expression.  Another potentially important factor is the ubiquitin-related 
protein PLIC-1, which has been suggested to stabilize intracellular GABAAR and prevent 
their degradation by the proteasome (Bedford et al., 2001).  Interference of the interaction 
between PLIC-1 and native GABAAR, via their α subunit variants, results in decreased cell 
surface expression, presumably due to enhanced degradation. Finally, palmytoylation of 
GABAAR has recently been shown to be essential for their postsynaptic clustering 
(Rathenberg et al., 2004).  This posttranslational modification involves cystein residues in 
the third cytoplasmic loop of the γ2 subunit, which is present in GABAAR clustered at 
postsynaptic sites. A possible candidate mediating palmytoylation is a novel GABAAR-
associated membrane protein, named Golgi apparatus-specific protein with the DHHC zinc 
finger domain (GODZ), and which selectively associates with the γ2 subunit (Keller et al., 
2004).  However, since GODZ is highly enriched in the Golgi apparatus, it is not yet clear 
whether it interacts also with newly internalized receptors. 
A second major question arises from the observation that the staining intensity of gephyrin 
clusters is reduced upon blockade of GABAAR internalization with the dynamin-inhibiting 
peptide. It has been shown previously that clustering of gephyrin depends on GABAAR 
clustering in both developing and mature synapses (Essrich et al., 1998; Schweizer et al., 
2003).  The present results suggest that the amount of gephyrin at postsynaptic sites is 
regulated on a short-time basis in function of the amount of GABAAR. In cultures from 
gephyrin-deficient mice, GABAAR clustering is only partially impaired, resulting in 
decreased amplitude of mIPSCs compared to wild type (Levi et al., 2004).  Our 
observations therefore raise the possibility that gephyrin plays a role for the clustering of the 
subsynaptic, intracellular pool of GABAAR, but not of receptors inserted in the cell 
membrane. 
The biotinylation assay revealed that the amount of internalized β3 subunit is larger than 
that of the β2 subunit (Fig. 5F), suggesting that endocytosis of the corresponding receptor 
subtypes is regulated differentially. A possible mechanism is the presence of consensus sites 
for phosphorylation by both PKC and PKA in the β3 subunit, whereas only PKA 
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phosphorylation sites are found on the β2 subunit (Kittler and Moss, 2003). In view of the 
differential role of these two kinases in regulating cell-surface expression of GABAAR, it is 
therefore conceivable that phosphorylation by PKC mediates most of the constitutive 
internalization occurring in our assay. However, since the β2 subunit is presumably 
associated mainly with the α1 subunit in interneurons, its internalization should be 
detectable in a more sensitive assay. 
 
Functional significance 
Endocytosis of ionotropic receptors is being recognized as a major facet of short- and long-
term synaptic plasticity.  As shown best for AMPA receptors, it is a highly regulated 
mechanism, involving differential interactions with distinct receptor subtypes and with 
scaffolding proteins (Bredt and Nicoll, 2003). An additional component is the lateral 
mobility of the receptors (Borgdorff and Choquet, 2002), allowing a rapid exchange 
between synaptic and extrasynaptic receptors, and differential endocytosis of the two 
receptor populations (Ashby et al., 2004; Groc et al., 2004). Much less is known about the 
mobility of receptors mediating synaptic inhibition, such as glycine receptors (Meier et al., 
2001) and GABAAR (Meissner and Haberlein, 2003), in spite of the fact that the latter are 
the target of clinically important drugs used to treat chronic disorders, such as epilepsy or 
anxiety. Although a rapid trafficking of cell-surface receptors has been demonstrated 
(Tehrani and Barnes, 1997; Wan et al., 1997), the effects of chronic drug exposure, in 
particular benzodiazepines, are controversial. While tolerance to the pharmacological action 
of these drugs does not involve major changes in GABAAR expression (van Rijnsoever et 
al., 2004), internalization of recombinant receptors expressed in Sf9 cells has been reported 
upon long-term diazepam exposure (Ali and Olsen, 2001). Increased internalization of the 
α1 subunit occurred only after a 7-day lorazepam treatment (Tehrani and Barnes, 1997), 
whereas a similar treatment with flurazepam resulted in decreased PKA activity correlating 
with reduced mIPSCs in slices from treated animals (Lilly et al., 2003). The possible 
involvement of internalization mechanisms during the development of tolerance to 
benzodiazepines is supported by the observation that tolerance is reversed quickly upon 
administration of the antagonist flumazenil, suggesting that it is based on a rapidly 
reversible biochemical process (Gonsalves and Gallager, 1988; Tietz et al., 1999).  
However, in contrast to these speculations, the present findings of a large pool of GABAAR 
directly under the synaptic membrane rather suggest that GABAAR endocytosis contributes 
to short-term regulation of GABAergic inhibitory transmission in direct response to acute 
changes in network activity, thereby providing a novel mechanism of synaptic plasticity.  
Furthermore, the observation that GABAAR expression is upregulated in chronic diseases 
such as epilepsy (Loup et al., 2000; Knuesel et al., 2001) suggests that dysregulation of the 
trafficking mechanisms contributes to the pathophysiology of these disorders. 
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Abstract 
Despite its pharmacological relevance, the mechanism of the development of tolerance to 
the action of benzodiazepines is largely unknown. The acute sedative action of diazepam is 
mediated via α1-GABAA receptors. It was therefore tested whether chronic activation of 
these receptors by diazepam is sufficient to induce tolerance to its sedative action. Knock-in 
mice, in which the α1-, α2-, α3- or α5-GABAA receptors had been rendered diazepam-
insensitive by histidine/arginine point mutation, were chronically treated with diazepam (8 
days, 15 mg/kg/day) and tested for motor activity. Wild type, α2(H101R), and α3(H126R) 
mice showed a robust diminution of the motor depressant drug action. In contrast, 
α5(H105R) mice failed to display any sedative tolerance. α1(H101R) mice showed no 
alteration of motor activity upon chronic diazepam treatment. Autoradiography with 
[3H]flumazenil revealed no change in benzodiazepine binding sites. However, a decrease of 
α5-subunit radioligand binding was detected selectively in the dentate gyrus with specific 
ligands. This alteration was observed only in diazepam-tolerant animals, indicating that the 
manifestation of tolerance to the sedative action of diazepam is associated with a down 
regulation of α5-GABAA receptors in the dentate gyrus. Thus, the chronic activation of α5-
GABAA receptors is crucial for the normal development of sedative tolerance to diazepam, 
which manifests itself in conjunction with α1-GABAA receptors.   
 41
     Publication  2   
Introduction 
Loss of sedative efficacy of diazepam upon chronic treatment has been proposed to result 
from the development of adaptive processes counteracting the repeated enhancement by the 
benzodiazepine of γ-aminobutyric acid (GABA)A receptor-mediated inhibitory 
neurotransmission (Fernandes et al., 1996; Marin et al., 1996; File and Fernandes, 1994; 
Steppuhn and Turski, 1993; Marin et al., 1999; Perez et al., 2003). Functional alterations of 
GABAA receptors have frequently been reported upon various chronic treatment regimens 
with diazepam (Hutchinson et al., 1996; Bateson, 2002; Costa et al., 2001; Itier et al., 1996; 
Primus et al., 1996; Ali and Olsen, 2001). Uncoupling of the allosteric interaction between 
the benzodiazepine binding site and the GABA site, probably linked to GABAA receptor 
internalisation, has been proposed as a correlate of diazepam tolerance (Hutchinson et al., 
1996; Costa et al., 2001; Ali and Olsen, 2001; Itier et al., 1996; Primus et al., 1996). 
Furthermore, subtle changes in the expression of GABAA receptor subunits were described 
notably in the cerebral cortex and hippocampus (Wu et al., 1994; Arnot et al., 2001; 
Impagnatiello et al., 1996; Pesold et al., 1997). In particular, a selective decrease in the 
expression of genes encoding the α1- and γ2-subunits in dendrites and spines of cortical 
pyramidal cells has been associated with tolerance to the anticonvulsant action of diazepam 
(Costa et al., 2002). In addition, α5-GABAA receptors were affected, as shown by an 
increase in α5-subunit mRNA in frontoparietal cortex or a reduced radioligand binding in 
hippocampus after two or three weeks of diazepam administration (Impagnatiello et al., 
1996; Pesold et al., 1997; Li et al., 2000). 
 
The recognition of distinct pharmacological functions of GABAA-receptor subtypes opened 
new avenues to investigate the mechanisms of tolerance. Using a histidine-to-arginine point 
mutation strategy that selectively abolishes diazepam binding to GABAA receptors 
containing the  α1-, α2-, α3- or α5-subunit in vivo, it has been shown that α1-GABAA 
receptors mediate the acute sedative (Rudolph et al., 1999; McKernan et al., 2000) and 
anticonvulsant (Rudolph et al., 1999) properties of diazepam, whereas α2-GABAA receptors 
are the substrate for anxiolytic (Löw et al., 2000) and muscle relaxant activity, the latter 
requiring also α3- and α5-GABAA receptors (Crestani et al., 2001; Crestani et al., 2002). In 
view of such functional receptor specificity, it was tested whether tolerance to a particular 
effect of diazepam is mediated via the same receptor subtype involved in the acute effect, or 
whether additional GABAA receptor subtypes are required for neuronal plasticity leading to 
the development of tolerance upon chronic diazepam treatment. 
In the present study, the contribution of specific GABAA-receptor subtypes in the 
development of tolerance to the motor depressant action of diazepam was examined using 
wild type and histidine/arginine point mutated mice. Potential changes in benzodiazepine-
binding sites were analyzed by autoradiography. 
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Methods 
Animals and drugs. 9- to 11-week old female wild type, α1(H101R), α2(H101R), 
α3(H123R), and α5(H105R) mice (> 10 backcrosses to 129/SvJ background) were used 
(Rudolph et al., 1999; Löw et al., 2000; Crestani et al., 2002). The histidine/arginine 
substitution in the GABAA receptor α1-, α2, α3- or α5-subunit results in a marked 
reduction of the binding affinity of the corresponding GABAA receptor subtype to 
diazepam, as shown on recombinant receptors (Benson et al., 1998). Thus, each point-
mutated mouse line possesses a particular GABAA receptor subtype insensitive to allosteric 
modulation by diazepam whilst its response to GABA is largely preserved. Females were 
preferred to males because of the prominent intramale aggressive behaviour inherent to the 
strain used as genetic background. They were reared in group-housed cages in the testing 
room under reversed 12-hour light/dark conditions. Treatments and behavioral testing were 
performed during the dark phase. The Cantonal Veterinary Office of Zurich approved all 
experimental procedures. Diazepam was from F. Hoffmann-La Roche (Basel, Switzerland). 
 
Induction of sedative tolerance. Mice were subjected to daily injections of diazepam (10 
mg/kg at 10 am and 5 mg/kg at 4 pm; intraperitoneally) for 8 days in the home-cage. On 
day 9, half of the mice were given vehicle and the other half, the morning dose of 10 mg/kg 
of diazepam as test dose. Control animals, which received the vehicle (0.3% tween/saline 
solution) as chronic treatment, were distributed in two groups. One group was treated with 
vehicle and the other group with 10 mg/kg of diazepam. A fifth group of mice, which 
served as control for the effects of repeated injections, received a single diazepam (10 
mg/kg) injection as test dose. Animals were left undisturbed to experience the drug effects 
in the home-cage for 30 min. At the end of this period, they were placed in individual 
circular alleys (Imetronic, Pessac, France) for motor activity assessment, measured as the 
number of photocell interruptions, during a 10-min period. The term “test dose” was used to 
indicate the association of the last diazepam morning injection of the chronic treatment with 
the behavioural assessment. The terms “sedation” and “sedative”, as defined in Katzung 
(1995), indicate the drug-induced decrease of the animal’s spontaneous activity. 
Measurement of motor activity in rodents represents a standard behavioral assay for testing 
the sedative potential of drugs (Vogel, 2002). 
 
Quantitative receptor autoradiography. A second series of animals received the same 
chronic treatment regimen with either vehicle or diazepam. On day 9, tolerance to the motor 
depressant action of 10 mg/kg of diazepam was tested and the mice were sacrificed by 
decapitation 5 hours thereafter. Binding assays using [3H]flumazenil (NEN, Perkin-Elmer, 
Boston, USA), [3H]RY80 (Perkin-Elmer, Boston, USA) or [3H]L655708 (Amersham 
Biosciences Europe GmbH, Otelfingen, Switzerland), two ligands with a preferential 
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affinity for the α5-subunit (Skolnick et al., 1997; Quirk et al., 1996), were performed on 
transverse 12-µm brain cryosections (Fritschy et al., 1997). Briefly, after a 1-hr incubation 
with 12 nM of [3H]flumazenil or 2 nM of either [3H]RY80 or [3H]L655708 in 50 mM 
Tris/Cl at pH 7.5, the sections were exposed to a tritium sensitive phosphor screen (Packard 
Cyclone Storage Phosphor System) for 2 or 8 days, respectively. Adding 10 µM of 
clonazepam assessed unspecific labeling. The screens were digitized with a Packard 
Cyclone Scanner and labeling intensities were measured in motor cortex, striatum, nucleus 
accumbens, and hippocampal formation (CA1, CA3 stratum oriens/pyramidale and dentate 
gyrus) of both hemispheres. At the concentrations used, both [3H]RY80 and [3H]L655708 
have been reported to saturate with a high affinity α5-subunit binding sites in hippocampal 
membranes (Skolnick et al., 1997; Quirk et al., 1996; Sur et al., 1999). 
 
Statistics. Results, expressed as mean ± SE (or SD for binding studies), were analyzed 
using non-parametric Kruskall-Wallis analysis and, whenever appropriate, Mann-Whitney’s 
tests for post-hoc mean comparisons. 
 
Results 
Tolerance to the sedative action of diazepam in point-mutated mice 
To identify the diazepam-sensitive GABAA receptor subtypes implicated in sedative 
tolerance, we examined the potential of histidine/arginine point-mutated mice to develop 
tolerance against the motor depressant action of diazepam during the course of a chronic 
drug treatment regimen. We focused on this behavioral effect for two main reasons. Firstly, 
the effectiveness of diazepam in decreasing motor activity in rodents is considered as a 
valid behavioral manifestation of its sedative properties (Vogel, 2002). Secondly, this drug 
effect is exclusively mediated by α1-GABAA receptors, since it is abolished in α1(H101R) 
mice whilst unaltered in α2(H101R), α3(H126R) and α5(H105R) mice (Rudolph et al., 
1999; McKernan et al., 2000; Löw et al., 2000; Crestani et al., 2002).  
 
Sedative tolerance to diazepam, i.e. the diminution of its motor depressant action upon 
chronic treatment, was first analyzed using wild type and α1(H101R) mice. The different 
treatment conditions affected differently motor activity in wild type mice [H = 22.958, p < 
0.001, n = 6 to 7 mice per group]. In wild type mice chronically treated with vehicle, the 
administration of 10 mg/kg of diazepam was followed by a marked decrease in motor 
activity (p < 0.01 as compared with Veh-Veh) (Fig.1 a). This effect was comparable to that 
seen in mice, which received a single acute injection of diazepam. Mice chronically treated 
with diazepam did not show a reduction in motor activity in response to the test dose of 
diazepam (Diaz-Diaz) and were indistinguishable from mice challenged with vehicle (Diaz-
Veh) or from mice chronically treated with vehicle only (Veh-Veh) (Fig. 1 a). In 
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α1(H101R) mice, neither a single acute injection of diazepam (10 mg/kg) nor the chronic 
diazepam treatment altered the level of motor activity in comparison to the chronic vehicle 
treatment, as revealed by the lack of statistical significance of the overall analysis of the 
effects of the different drug treatment conditions [H = 5.914, not significant, n = 6 mice per 
group] (Fig. 1 b). The increased motor activity seen in chronically vehicle-treated 
α1(H101R) mice in response to diazepam achieved significance only when compared, in a 
separate two-mean comparison, to the effect of the vehicle test injection (p < 0.01, Mann-
Whitney) but not when compared to that induced by a single acute diazepam injection (Fig. 
Fig. 1. 
regime
1 b). 
Motor activity in wild type and point mutated mice subjected to an 8-day chronic diazepam treatment 
-sensitive GABA -receptor subtypes other than those 
n (15 mg/kg/day).  (a) In wild type mice, the test dose of diazepam (10 mg/kg) was equally effective in 
decreasing motor activity, when given either acutely or 18 hours after a chronic vehicle treatment. Mice 
chronically treated with diazepam showed levels of motor activity similar to that of mice chronically treated 
with vehicle, in response to either diazepam or vehicle [H = 22.958, p < 0.001, n = 6 to 7 mice per group].  (b) 
In α1(H101R) mice, there was no overall effect of the different treatment conditions on motor activity [H = 
5.914, not significant, n = 6 mice per group]. However, an increased motor activity was seen in animals 
chronically treated with vehicle in response to diazepam (p < 0.01 as compared with Veh-Veh, Mann-
Whitney).  (c) The test dose of diazepam decreased motor activity in animals chronically treated with the 
vehicle but not in those treated with diazepam in α2(H101R) [H = 14.942, p < 0.001, n = 8 mice per group] 
and α3(H126R) mice [H = 12.194, p < 0.002, n = 8 mice per group]. In α5(H105R) mice, the same diazepam 
test dose depressed motor activity in animals chronically treated with either vehicle or diazepam [H = 12.005, 
p < 0.002, n = 8 mice per group]. Results are given as means ± SE. ++, p < 0.01 versus Veh-Veh, Mann-
Whitney. Veh, vehicle; Diaz, diazepam. 
 
o characterize the role of diazepamT A
containing the α1-subunit in sedative tolerance, α2(H101R), α3(H126R), and α5(H105R) 
mice were subjected to the same chronic diazepam treatment regimen. There was a 
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significant overall effect of the different treatment conditions on motor activity in all three 
mutant lines [α2(H101R): H = 14.942, p < 0.001, n = 8 mice per group; α3(H126R) mice: 
H = 12.194, p < 0.002, n = 8 mice per group and α5(H105R) mice: H = 12.005, p < 0.002, n 
= 8 mice per group]. Diazepam (10 mg/kg) failed to decrease motor activity levels in 
α2(H101R) and α3(H126R) mice chronically treated with diazepam while it induced 
sedation in those mutants chronically treated with vehicle (p < 0.01 as compared with the 
respective Veh-Veh groups) (Fig. 1 c). In contrast, in α5(H105R) mice, the same test dose 
of diazepam was equally effective in depressing motor activity in animals chronically 
treated with either vehicle or diazepam (p < 0.01 as compared with Veh-Veh) (Fig. 1 c). 
Thus, tolerance to the motor depressant action of diazepam developed to the same extent in 
wild type, α2(H101R) and α3(H126R) mice within 8 days of chronic drug administration, 
whilst it failed in α5(H105R) mice; furthermore, the same chronic diazepam treatment 
regimen did not alter motor activity in α1(H101R) mice. 
 
Brain autoradiography of α5-GABAA receptor-binding sites 
epam would be associated 
o specifically analyze the role of α5-GABAA receptors, two selective α5-subunit ligands, 
To assess whether the expression of sedative tolerance to diaz
with alterations in GABAA receptor binding sites, we analyzed benzodiazepine binding 
autoradiographically with [3H]flumazenil in wild type, α1(H101R) and α2(H101R) mice. 
The levels of [3H]flumazenil binding differed across genotypes due to the presence of the 
respective point mutation (Fig. 2). However, no alteration in relation with the chronic drug 
treatment regimen and the behavioral testing was detected, in particular in forebrain regions 
involved in the control of motor activity, including primary motor cortex, striatum, and 
nucleus accumbens, as well as in the hippocampal formation (Fig. 2). Thus, there was no 
evidence for a general GABAA receptor down-regulation. 
 
T
[3H]RY80 and [3H]L655708, were used in the autoradiographic analysis. In wild type mice, 
the levels of [3H]RY80 binding were differentially affected by the three treatment 
conditions in the dentate gyrus [H = 14.769, p < 0.001, n = 7 to 8 mice per group] (Fig. 3 a). 
A significantly lower [3H]RY80 binding level (-13.6% relative to Veh-Veh) was observed 
in diazepam-tolerant animals (p < 0.01 as compared with Veh-Veh and Veh-Diaz). A 
similar effect of the chronic diazepam treatment was confirmed using [3H]L655708 as 
radioligand [H = 10.903, p < 0.004, n = 6 to 7 mice per group] (Fig. 3 b). The [3H]L655708 
binding level was significantly reduced (14.7% relative to Veh-Veh) only in tolerant mice 
(p < 0.01 as compared with Veh-Veh and Veh-Diaz).  
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3Fig. 2. Autoradiography of [ H]flumazenil binding after cessation of an 8-day treatment regimen with vehicle 
3 3
H]RY80 binding was further analyzed in α1(H101R) and α2(H101R) mice subjected to 
or diazepam (15 mg/kg/day) and administration of the test dose diazepam (10 mg/kg) in wild type, 
α1(H101R), and α2(H101R) mice. Irrespective of the genotype, the chronic diazepam treatment did not alter 
[3H]flumazenil binding compared to chronic vehicle or acute diazepam, as quantified for three regions 
involved in motor control and for the hippocampal formation. Standards and differential [3H]flumazenil 
binding profile related to the point-mutation are also presented in representative transverse sections from 
chronically vehicle-treated animals. The different binding levels in the mutant mice reflect the loss of 
diazepam binding to the mutated subunit. Results are expressed in mean nCi/mg protein ± SD, n = 4 – 7 mice 
per group. Veh, vehicle; Diaz, diazepam. 
 
In contrast, the effects of the three treatment conditions on [ H]RY80 and [ H]L655708 
binding levels were comparable in the hippocampal CA1 area [[3H]RY80: H = 1.563, not 
significant, n = 5 to 6 mice per group and [3H]L655708: H = 3.661, not significant, n = 6 to 
7 mice per group] as well as in the CA3 area [[3H]RY80: H = 4.662, not significant, n = 5 to 
6 mice per group and [3H]L655708: H = 1.988, not significant, n = 6 to 7 mice per group] 
(not shown). 
 
[3
the same chronic drug treatment and behavioral testing. In α2(H101R) mice, as in wild type 
mice, the chronic administration of diazepam was accompanied by sedative tolerance (not 
shown) and by a decrease of [3H]RY80 binding level in dentate gyrus (-12.5 % relative to 
Veh-Veh, p < 0.01) [H = 9.231, p < 0.009, n = 5 to 6 mice per group] (Fig. 3 c). The 
α1(H101R) mice displayed similar levels of [3H]RY80 binding, irrespective of the 
treatment conditions [H = 2.788, not significant, n = 5 to 6 mice per group] (Fig. 3 d). Thus, 
the manifestation of tolerance to the motor depressant action of diazepam was accompanied 
by an apparent reduction of α5-GABAA receptor binding selectively in the dentate gyrus, as 
shown for wild type and α2(H101R) mice. This reduction of α5-subunit binding did not 
occur in α1(H101R) mice subjected to the same chronic diazepam treatment.  
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Fig. 3. Alteration of α5-GABAA receptor 
binding in dentate gyrus after cessation of 
an 8-day treatment regimen with vehicle 
or diazepam (15 mg/kg/day), assessed 
autoradiographically with [3H]RY80 and 
[3H]L655708 in wild type (a, b), and with 
[3H]RY80 in α2(H101R) mice (c) and 
α1(H101R) (d). Standards and 
representative transverse sections from 
mice chronically treated with vehicle are 
shown. (a) [3H]RY80 binding levels were 
decreased in wild type mice chronically 
treated with diazepam.  (b) A similar 
decrease of [3H]L655708 binding level 
was observed in the same wild type mice.  
(c) In α2(H101R) mice, only animals 
chronically treated with diazepam showed 
a significant reduction of [3H]RY80 
binding.  (d) In α1(H101R) mice, no 
alteration in [3H]RY80 binding was seen, 
irrespective of the chronic drug treatment. 
Results are given as mean nCi/mg protein 
± SD. ++, p < 0.01 versus Veh-Veh, **, p 
< 0.01 versus Veh-Diaz, Mann-Whitney 
test. Veh, vehicle; Diaz, diazepam 
Discussion 
The present results point to a critical role of α5-GABAA receptors, in conjunction with α1-
GABAA receptors, for the development of tolerance against the sedative action of diazepam. 
Interaction of diazepam with α5-GABAA receptors appears to be a prerequisite for the 
normal development of tolerance against its motor depressant action. This is shown by the 
retained capacity of diazepam (10 mg/kg) to reduce efficiently motor activity in α5(H105R) 
mice, which possess diazepam-insensitive α5-GABAA receptors, at least within the limits of 
our chronic drug treatment regimen (Fig. 1 c). This motor effect cannot be attributed to a 
retained myorelaxant action of diazepam, since we have shown that these mutants, as well 
as the α2(H101R) mice, do not express the acute myorelaxant action of diazepam in the 
range of doses used for the chronic treatment (Crestani et al., 2001; Crestani et al., 2002). 
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On the other hand, α2(H101R) and α3(H126R) mice developed sedative tolerance to 
diazepam to the same extent as wild type mice (Fig. 1 c), indicating that diazepam-sensitive 
α2- or α3-GABAA receptors are not essential for this effect. In rodents, tolerance to the 
motor depressant action of diazepam develops rapidly, within 3 to 5 days of chronic 
administration (Marin et al., 1996; File & Fernandes, 1994; Steppuhn & Turski, 1993). We 
designed a chronic treatment protocol, using high doses of diazepam over a period of 9 
days, in order to induce a robust sedative tolerance in our control wild type mice. 
Nevertheless, we cannot rule out the possibility of a delayed occurrence of sedative 
tolerance, i.e. upon a longer chronic diazepam treatment, in α5(H105R) mice. Conversely, 
the absence of motor depressant drug effect in wild type mice, α2(H101R) and α3(H126R) 
mice upon chronic treatment could reflect a rightward shift in the dose-response curve of 
diazepam, so that the same chronically diazepam-treated animals would show sedation in 
response to higher doses of diazepam (>10 mg/kg). However, this appears improbable, 
especially with regard to our test conditions. Motor activity was measured 30 mn after the 
last diazepam injection of the chronic treatment, and not after a period of drug withdrawal 
as this is often the case in the literature, in order to assess the retained sedative drug efficacy 
at a particular time of the chronic diazepam treatment regimen. To our knowledge, only the 
study of Perrault et al. (1993), using the anticonvulsant action of diazepam as endpoint, 
described a rightward and downward shift in the dose-response curve of diazepam, but only 
when the test dose was given 42 hours after termination of a 10-day chronic treatment 
regimen (2 x 5 mg/kg po). This shift was attributed to the rapid development of a 
hypersensitivity of the mice to the convulsant drug, in relation to diazepam withdrawal 
experience. A significant residual anticonvulsant action of diazepam was seen in chronically 
treated animals when the convulsant drug was administered 6 hours after the last diazepam 
dose (Perrault et al., 1993). 
 
The diminution of motor activity seen in α5(H105R) mice upon chronic diazepam treatment 
further reveals that, during the course of the chronic diazepam treatment,  α1-GABAA 
receptors remain responsive, mediating recurrently sedation, in these mutants. Therefore, 
sedative tolerance appears not to be due to a reduction of the motor depressant efficacy of 
diazepam, thus confirming a previous report (Bourin et al., 1992). Rather, its manifestation 
might be secondary to the development of an α5-GABAA receptor-dependent response to 
chronic diazepam, which would oppose its motor depressant action. In α1(H101R) mice, 
which do not display the sedative drug action, chronic interaction of diazepam with GABAA 
receptors other than those containing the α1 subunit was not associated with change in 
motor activity (Fig. 1 b). This result argues against an oppositional α1-GABAA receptor-
independent mechanism, which would counterbalance, thus masking, the sedative drug 
action. α1- and α5-GABAA receptors appear to be the specific molecular substrates 
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contributing in a competitive manner to the chronic effects of diazepam on motor activity. 
Chronic interaction of diazepam with α1-GABAA receptors results in a recurrent motor 
depressant action while the concurrent interaction with α5-GABAA receptors is essential for 
the behavioral manifestation of tolerance to this effect. This result is in line with reports that 
benzodiazepine site ligands that do not interact with α5-GABAA receptors, such as 
zolpidem, show little or no evidence for sedative tolerance in rodents and fail to alter α5-
subunit levels (Zivkovic et al., 1994; Costa and Guidotti, 1996; Holt et al., 1997). 
 
The α5-GABAA receptors of the dentate gyrus appear to be a specific target for adaptive 
changes associated with sedative tolerance to diazepam. Indeed, a down regulation of α5-
GABAA receptors, as assessed with two selective α5-subunit radioligands used at saturating 
concentrations, was observed only in wild type and α2(H101R) mice tolerant to the motor 
depressant action of diazepam (Fig. 3 a, b, and c). This reduction of receptors was restricted 
to the dentate gyrus. No change in α5-subunit radioligand binding levels was detected in the 
hippocampal CA1 and CA3 area of these animals. Within the limits of statistical power, a 
decreased binding of α5-subunit-specific radioligands in diazepam-tolerant animals could 
be resolved only in the hippocampal formation. We do not exclude that the chronic 
diazepam treatment regimen used here can give rise to alterations in α5-GABAA receptors 
in other brain regions. However, the unchanged levels of [3H]flumazenil binding in 
forebrain regions involved in control of motor activity argues against a general down-
regulation of GABAA receptors, as well as against a regionally-specific loss of another 
major GABAA receptor subtype after chronic diazepam treatment. This observation is in 
concordance with many other reports that flumazenil binding sites remain unaltered upon 
chronic benzodiazepine treatment (Hutchinson et al., 1996; Bateson, 2002; Costa et al., 
2001). The absence of alteration in α5-subunit radioligand binding in α1(H101R) mice 
chronically treated with diazepam (Fig. 3 d) further indicates that occurrence of the α5-
GABAA receptor down-regulation in the dentate gyrus closely depends on the chronic 
interaction of the drug with α1-GABAA receptors but not with GABAA receptors containing 
the α2-, α3- or α5-subunit. 
 
α5-GABAA receptors constitute a minor population of diazepam-sensitive GABAA 
receptors. They are found mainly in the hippocampal formation, olfactory bulb granule cell 
layer, and spinal cord dorsal horn, and in lower amounts, in the cerebral cortex and 
hypothalamus (Crestani et al., 2002). We have previously reported that the H105R point 
mutation in the α5 subunit gene resulted in a reduction of α5-GABAA receptors in the 
dendritic layers of the hippocampal CA1 and CA3 areas with no change in the dentate gyrus 
(Crestani et al., 2002). Although this specific deficit of receptors in α5(H105R) mice 
mimics to some extent the molecular changes seen in the dentate gyrus of diazepam-tolerant 
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animals, it does not interfere with the expression of the motor depressant action of 
diazepam, whenever given acutely (Crestani et al., 2002) or chronically (Fig. 1 c). This is in 
keeping with the lack of alteration in the expression pattern of the other major GABAA 
receptor subunits, notably the α1-subunit, in α5(H105R) mice (Crestani et al., 2002) as well 
as in mice with a complete loss of hippocampal α5-GABAA receptors (Collinson et al., 
2002). Thus, it is not a reduction in the expression of α5-GABAA receptors per se, but 
rather its selective localization in the dentate gyrus, which appears to be associated with the 
expression of sedative tolerance to diazepam. Likewise, the induction of long-term 
potentiation in hippocampal pyramidal cells is unaltered in α5(H105R) mice (Crestani et 
al., 2002) whereas tolerance to the motor depressant action of diazepam is associated with 
an increased synaptic plasticity in the rat dentate gyrus (Marin et al., 1996). Therefore, the 
failure of α5(H105R) mice to manifest sedative tolerance, despite their partial deficit in 
hippocampal α5-GABAA receptors, strengthens the hypothesis that diazepam binding to 
α5-GABAA receptors is a key mechanism underlying the robust diminution of its sedative 
efficacy upon chronic treatment. This is the more striking, as these receptors are mainly 
extrasynaptic and mediate tonic inhibition in hippocampal CA1 pyramidal cells (Crestani et 
al., 2002; Caraiscos et al., 2004). The association of changes in α5-subunit binding sites, 
mRNA, or protein levels with tolerance to diazepam has been reported previously for its 
anticonvulsant properties (Li et al., 2000; Pesold et al., 1997; Impagnatiello et al., 1996; Wu 
et al., 1994). Here, we demonstrate that the decrease in α5-subunit binding in the dentate 
gyrus depends on the chronic activation by diazepam of α1-GABAA receptors, which 
primarily produce phasic inhibition in the brain. This is in keeping with the reported high 
plasticity in the expression of hippocampal extrasynaptic α5-GABAA receptors in response 
to intense synaptic activity (Houser and Esclapez, 2003).  
 
In conclusion, we propose that the manifestation of tolerance to the motor depressant action 
of diazepam depends on the chronic activation of two competitive mechanisms orchestrated 
by respectively α1- and α5-GABAA receptors. 1) Chronic drug interaction with α1-GABAA 
receptors results in a persistent augmentation of the phasic inhibition in the forebrain areas 
involved in motor control, mediating motor depression. This recurrent increased phasic 
signaling would alter the weight of the tonic inhibition produced by 2) the simultaneous 
drug activation of extrasynaptic α5-GABAA receptors in the hippocampal formation. The 
α1-GABAA receptor-dependent changes in inhibitory efficacy, which occurs during the 
course of the chronic diazepam treatment, is reflected by the 15% diminution of α5-GABAA 
receptors in the dentate gyrus of tolerant animals. This is in keeping with the potential of a 
small reduction in the efficacy of GABAA receptor-mediated inhibition (~10%) to markedly 
increase cortical excitation (Chagnac-Amitai and Connors, 1989). Tolerance against the 
motor depressant action of diazepam has been associated with an enhancement of both 
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hippocampal synaptic efficacy and NMDA receptor subunit mRNAs expression in dentate 
gyrus (Marin et al., 1996; Perez et al., 2003). Moreover, it has been reported that acute 
application of diazepam on hippocampal slices prevents the long-term potentiation of 
population spikes, whereas zolpidem has no effect, suggesting a possible α5-GABAA 
receptor-dependent mechanism (Higashima et al., 1998). We do not exclude a 
compensatory alteration in diazepam-insensitive tonic inhibition mediated by δ-subunit 
containing GABAA receptors in the dentate granule cells, which could contribute to the 
increase in hippocampal excitability upon chronic diazepam treatment (Nusser and Mody, 
2002). However, the high relative abundance of diazepam-sensitive α5-GABAA receptors in 
the hippocampal formation positions this structure as a key player for development of the 
sedative tolerance phenotype by means of its widespread efferent connections to brain areas 
involved in the regulation of motor control.  
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3.3  Selective enhancement of α1-GABAA receptor activity by zolpidem is 
insufficient to induce full sedative tolerance and hippocampal α5-
GABAAR downregulation. 
 
C. van Rijnsoever, M. Täuber,  J.-M. Fritschy, F. Crestani 
 
In preparation. 
 
Introduction 
The tolerance liability of benzodiazepine site ligands depends on their efficacy (Johnston 
and Bristow, 1998) and subtype selectivity (Bateson, 2002). Full agonists that bind to all 
diazepam-sensitive GABAA receptor (GABAAR) subtypes with the same affinity are more 
prone to the development of tolerance then partial agonist such as imidazenil (Auta et al., 
1994). In recent years, subtype specific ligands, such as zolpidem, were developed that 
showed only limited tolerance to their effects in rodents and in clinical practice (Rush, 
1998). Zolpidem is an imidazopyridine with a high affinity for α1-containing GABAAR, an 
intermediate affinity for α2- and α3-, and a very low affinity for α5-GABAAR (Sanna et al., 
2002). Our previous study demonstrated that induction of sedative tolerance to diazepam 
requires chronic activation of both α1- and α5-GABAAR subtypes and is associated with 
decreased α5 binding sites in the dentate gyrus (van Rijnsoever 2004, previous chapter). 
Most importantly, the lack of sedative tolerance of α5(H101R) mice implies that α1-
GABAAR remain pharmacologically responsive during the course of the chronic diazepam 
treatment. This suggests that the low tolerance to zolpidem is perhaps due to lack of 
enhancement of tonic inhibition mediated by α5-GABAAR. Consequently one would also 
expect that changes in α5 binding sites associated with diazepam tolerance would not be 
detected after chronic zolpidem treatment. However, because of the point mutation, it could 
not be assessed in α5(H101R) whether any change occurs in α5 binding sites. As we have 
shown that the α2- and the α3-GABAAR subtypes are redundant for the development of 
sedative tolerance, zolpidem, with its high affinity for α1 subunit, should be able to mimic 
the situation seen in diazepam-treated α5(H101R) mice. We examined the ability of chronic 
zolpidem treatment to induce tolerance to its sedative action and to induce changes in the 
number of α5-GABAAR binding sites in wild type mice. The effects of an acute sedative 
dose of zolpidem on the molecular changes associated with sedative tolerance to diazepam 
were tested as well. 
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Materials & Methods 
 
Animals and drugs. 9- to 11-week old female wild type mice (129/SvJ and NMRI 
background) were used. They were reared in group-housed cages in the testing room under 
reversed 12-hour light/dark conditions. Treatments and behavioral testing were performed 
during the dark phase. The Cantonal Veterinary Office of Zürich approved all experimental 
procedures. Diazepam was from F. Hoffmann-La Roche (Basel, Switzerland); Zolpidem 
from Sanofi-Synthelabo Recherches (Chilly Mazarin, France). [3H]L655708 was from 
Amersham (Amersham Biosciences Europe GmbH, Otelfingen, Switzerland). 
Chronic drug treatment. Mice were subjected to daily intraperitoneal injections of diazepam 
or zolpidem (10 mg/kg at 10 am and 5 mg/kg at 4 pm for 8 days in their home-cage; the 
dose for zolpidem was adapted from the sedative ED50 found by Sanger et al. (1996). On 
the 9th day, i.e. 18 hours after the last injection, the mice received a test drug dose: Vehicle 
treated mice received vehicle, diazepam (10 mg/kg) or zolpidem (10 mg/kg). Diazepam 
treated mice received a test dose of diazepam (10 mg/kg) or zolpidem (10 mg/kg). Mice 
chronically treated with zolpidem received a test dose of zolpidem (10 mg/kg). They were 
left undisturbed to experience the drug effects in the home-cage for 30 min. At the end of 
this period, sedative tolerance was tested behaviorally by assessing motor activity measured 
as the number of photocell interruptions in individual circular alleys (Imetronic, Pessac, 
France) for 10 min. The mice were then returned to their home-cage and were sacrificed 5 
hours later for autoradiography. 
To examine the time course for drug effects on motor activity, a separate group of NMRI 
mice (Harlan Netherlands, Horst, the Netherlands) was treated for 8 days with vehicle, 
diazepam or zolpidem, as described above. On day 9, they were placed in individual 
circular alleys for measuring motor activity for 1 hour, starting immediately after injection 
of the test dose. The NMRI strain is an inbred strain, classically used in behavioral 
pharmacology for assessing motor drug effects (Wolffgramm et al., 1994; Gaddnas et al., 
2001; Millan et al., 2003).  
Autoradiography. Binding assays using [3H]L655708, a radioligand with a preferential 
affinity for the α5-subunit, were performed on transverse 12-µm brain cryosections. Briefly, 
after a 1-hr incubation with a saturating dose (2 nM) [3H]L655708 in 50 mM Tris/Cl at pH 
7.5, the sections were exposed to a tritium sensitive phosphor screen (Packard Cyclone 
Storage Phosphor System) for 8 days. Adding 10 µM of clonazepam assessed unspecific 
labeling. The screens were digitized with a Packard Cyclone Scanner and labeling 
intensities were measured in the hippocampal formation (CA1, CA3 stratum 
oriens/pyramidale and dentate gyrus) of both hemispheres.  
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Statistics. Results, expressed as mean ± SE, were analyzed using non-parametric Kruskal-
Wallis analysis and, whenever appropriate, Mann-Whitney’s tests for mean comparisons. 
For the time course, a two-way ANOVA was conducted on the first 40 min. of recording 
followed by a Least Significant Difference test for mean comparisons. 
 
Results  
Partial tolerance to the sedative action of zolpidem with chronic treatment 
We tested whether a chronic treatment with zolpidem led to tolerance against its sedative 
action in our wild type mice. Zolpidem, given at the dose of 10 mg/kg after the chronic 
vehicle treatment, induced a marked reduction in motor activity (Fig 1a, P<0.01 compared 
to Veh-Veh). The same test dose of zolpidem was effective in depressing motor activity 
(P<0.01, compared to Veh-Veh) but to a much lesser extent in mice chronically treated with 
zolpidem (Fig. 1a; P<0.01, compared to Veh-Zolp) [H 17.90, P<0.001, n= 7 to 8 mice per 
group]. For comparison, full tolerance to the sedative effect of diazepam developed with 
chronic administration (Fig 1b; P<0.05 compared to Veh-Diaz).   
To test if the lack of motor depression seen in chronically diazepam-treated mice after 
administration of the test dose of diazepam reflected an absolute loss of α1-GABAA 
receptor-mediated responsiveness, we challenged diazepam-tolerant animals with 10 mg/kg 
of zolpidem. In response to zolpidem, diazepam-tolerant mice displayed a reduction in 
motor activity (Fig 1b; P<0.05, compared to Diaz-Diaz; P<0.05, compared to Veh-Veh), 
which was similar to that seen in chronically vehicle-treated mice after acute administration 
of diazepam  [H=13.70, P<0.01, n= 7 to 8 mice per group] (Fig 1b). The sedative action of 
zolpidem observed in diazepam-tolerant wild type mice mimicked the retained sedative 
action of diazepam in α5(H105R) mice with chronic diazepam treatment (Fig 1c; from van 
Rijnsoever et al 2004). Indeed, these mutant mice, in which the same GABAAR subtypes 
are stimulated by diazepam as in zolpidem-treated wild type mice, displayed a decreased 
motor activity with both acute and chronic diazepam treatment and thus failed to develop 
sedative tolerance to diazepam (Fig 1c; P<0.01 versus Veh-Veh) [H=12.009, P<0.002, n= 8 
mice per group]. 
 
No change in α5 binding sites after acute or chronic zolpidem administration 
[3H]L655708 autoradiography was performed on the wild type animals used in the 
behavioral experiment described above. As previously shown, chronic, but not acute, 
administration of diazepam was accompanied by a reduction of α5 binding sites in the 
dentate gyrus from wild type mice (Fig 2; P<0.01, compared to Veh-Veh and Veh-Diaz). In 
mice chronically treated with vehicle, zolpidem or diazepam and challenged with the test 
dose of zolpidem, [3H]L655708 levels were comparable to those of mice chronically treated 
with vehicle only [F5, 37=5.127, P<0.001, n = 6 to 8 mice per group] (Fig. 2).  
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Fig 1. Effects of a test dose of zolpidem (10 mg/kg) or diazepam (10mg/kg) on motor activity after an 8-day 
treatment regimen with vehicle, zolpidem (15mg/kg/day) (a), or diazepam (15mg/kg/day) (b and c). (a) A test 
dose of zolpidem reduced motor activity in wild type mice chronically treated with vehicle, whereas this 
sedative effect was significantly attenuated after an 8-day zolpidem treatment regimen [H=17.90, p<0.001, 
n=7 to 8 mice per group]. (b) A test dose of diazepam depressed motor activity in vehicle-treated, but not 
diazepam-treated wild type mice. However, zolpidem (10mg/kg) was capable of reducing motor activity in 
mice that had received chronic diazepam [H=13.70, p<0.01, n=7 to 8 mice per group]. (c) α5(H101R) mice 
displayed reduced motor activity after acute and chronic diazepam treatment [H=12.005, p<0.002, n=8 mice 
per group, from van Rijnsoever et al. 2004]. Results are given as mean ± SE; + p<0.05, ++ p<0.01 versus Veh-
Veh; ** p<0.01 versus Veh-Zolp; * p<0.05 versus Veh-Diaz; * p<0.05 versus Diaz-Diaz. Mann Whitney tests. 
Veh, vehicle; Zolp, zolpidem; Diaz, diazepam. 
 
 
Fig 2. Levels of [3H] L-655708 in dentate gyrus the day following cessation of a 8-day treatment with 
zolpidem (15 mg/kg/day), diazepam (15 mg/kg/day) or vehicle. Mice which were chronically or acutely 
treated with zolpidem showed no reduction in [3H]L655708 binding in dentate gyrus 5 hours after injection of 
the test dose of zolpidem. Diazepam-treated mice displayed a decreased level of [3H]L655708 binding in the 
dentate gyrus as shown previously after a test dose of diazepam  (++, P < 0.01 compared with Veh/Veh and 
Veh/Diaz) but not after the test dose of zolpidem (*, P < 0.05 compared with Diaz/Diaz) [F5, 37=5.127, P < 
0.001, n = 6 to 8 mice per group]. Results are given as means ± SE.Veh, vehicle; Diaz, diazepam; Zolp, 
zolpidem. 
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It is noteworthy that in diazepam-tolerant mice, the sedative zolpidem treatment was not 
associated with a downregulation of α5 binding sites (P<0.05 as compared to Diaz-Diaz, 
Fig. 2). No differences were observed in CA3 or CA1 (not shown). In conclusion, acute or 
chronic treatment with zolpidem has no effect on the expression of α5 binding sites in the 
dentate gyrus, even in diazepam-tolerant animals. 
 
Sedation in chronically zolpidem treated mice immediately after injection 
Although a partial tolerance to the motor depressant action of zolpidem was detected 30 min 
after the last injection, it was observed that animals chronically treated with zolpidem 
displayed sedation within minutes following zolpidem injection. Therefore, in a second 
experiment with NMRI mice, the effect of chronic zolpidem administration on motor 
activity was measured immediately after the test dose with zolpidem (10 mg/kg). Two other 
groups, treated chronically and tested with vehicle or diazepam in the same conditions, were 
used for comparison. In vehicle treated mice, motor activity is generally high in the first 5 
minutes, reflecting the behavioral arousal induced by the stress and the novelty of the 
experimental situation. This gradually decreases over time and stabilizes to a certain level 
with habituation. The time course of motor activity was different in mice chronically treated 
with zolpidem compared to vehicle treated controls (Treatment F1,7= 38.60, P<0.001, Time 
F1,7= 23.70, P<0.001, Treatment x Time F1,7,= 6.780, P<0.001). Zolpidem was inactive 
during the first 5 min following injection, as shown by the similar amount of motor activity 
in zolpidem and vehicle treated animals. However, from the next 5 min and for 15 min, 
zolpidem suppressed motor activity (10-15 min. P< 0.01; 20 min. P<0.05; compared to 
vehicle treated controls, Fig 3). This effect slowly disappeared 25 min after injection (Fig 
3). The time course of motor activity under chronic diazepam treatment did not differ from 
that seen in vehicle treated animals (Treatment F1,7= 3.596, not significant, Time F1,7= 
22.424, P<0.001, Treatment x Time F1,7= 1.446, not significant) (Fig. 3). 
 
 
ig 3. Time course of motor activity in mice chronically treated and tested with vehicle (♦), diazepam () or F
zolpidem (U) for 8 days.  Motor activity was measured immediately after the last drug injection for 1 hour. 
Only the first 40 min. are shown. Note the marked motor depressant effect of zolpidem during the firts10 to 25 
min. Post-injection, which gradually declines over time and the absence of difference between diazepam and 
vehicle-treated animals (*p<0.05, **p<0.01, compared to vehicle; Least Significant Difference test).   
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Thus, following 8 days of chronic administration, zolpidem was effective in suppressing 
motor activity during the first 20-25 min following the last injection whereas diazepam was 
not effective at all.  
 
Discussion 
ce, an 8-day chronic treatment with zolpidem is associated with a decrease in 
 first explanation for the reduced sedative effectiveness in mice chronically treated with 
In 129/SvJ mi
its motor depressant action, as tested 30 min after the last injection, which suggests a partial 
development of sedative tolerance. However, the analysis of the time course of the sedative 
effect of zolpidem after the same chronic drug treatment regimen, using NMRI mice, 
reveals a potent motor depressant drug effect during the first 20 min following the last 
injection (10 mg/kg), which gradually disappears after 30 min. For comparison, in both 
129/SvJ wild type and NMRI mice, a single injection of 10 mg/kg of zolpidem results in a 
marked decrease in motor activity for at least 1 hour (data not shown & personal 
communication from F. Crestani). In contrast, the chronic administration of diazepam gives 
rise to the development of a robust sedative tolerance, as demonstrated by the lack of 
changes in motor activity following the last injection. Our results suggest that the potential 
of zolpidem to produce sedative tolerance with chronic administration is only partial, and 
within the limits of our conditions, it likely reflects a quicker recovery of the mice from the 
drug effect. This demonstrates that the time of measurement is important when assessing 
behavioral tolerance against a drug effect. Little or no tolerance to zolpidem has been 
reported in rodents (Sanger and Zivkovic, 1987; Perrault et al., 1992; Elliott and White, 
1999). Sanger & Zivkovic found a small degree of tolerance to zolpidem, using a fixed-ratio 
lever press test in rats, a result that was never replicated (Sanger and Zivkovic, 1987, 1992). 
The only study conducted in mice, reporting no sedative tolerance, used very high doses of 
zolpidem (30 mg/kg, twice daily) and measured motor activity 42 hours after cessation of 
drug treatment, i.e. in a state of drug withdrawal (Perrault et al., 1992), whereas we tested 
the efficacy of the drug within the time frame of the chronic drug administration. However, 
in baboons, no difference was found between zolpidem and classical benzodiazepines with 
regard to tolerance to the ataxic effect (Griffiths et al., 1992). In humans, clinical trials did 
not reveal any tolerance after chronic zolpidem treatment (Voderholzer et al., 2001), 
however, case reports of tolerance to zolpidem are known (Sakkas et al., 1999; Aragona, 
2000). 
 
A
zolpidem is a faster turnover of the ligand. However, it is unlikely that this early recovery 
from the sedative effect of zolpidem results from a change in drug metabolism, because no 
pharmacokinetic change has been reported with chronic zolpidem administration (Trenque 
et al., 1994) or chronic classical benzodiazepine treatment (Hutchinson et al., 1996). 
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Secondly, it has been suggested that a mechanism involved in the development of tolerance 
might be endocytosis of cell-surface GABAAR (Tehrani and Barnes, 1997; Ali and Olsen, 
2001). In transfected cells and rat brain α1-containing GABAAR are internalized after 
chronic benzodiazepine treatment. The sedation produced by the test dose of zolpidem 
implies that no internalization of α1-GABAAR had taken place, which is in line with the 
sedation observed in α5(H101R) mice after chronic diazepam treatment (Fig.1c). If 
endocytosis of GABAAR played a major role in the development of this partial tolerance 
with chronic zolpidem treatment, the reduction of its motor depressant efficacy should have 
been evident immediately after the test injection, which is the case with chronic diazepam 
treatment. We demonstrated here that the sedation of zolpidem per se is not affected, only 
its duration.  
It was recently shown that the acute motor depressant action of zolpidem depends 
e showed before that no major change occurs on total benzodiazepine binding sites, and 
exclusively on the activation of α1-GABAAR (Crestani et al., 2000, personal 
communication from F. Crestani). Therefore a third possibility is that the shortened sedative 
efficacy of zolpidem may be the manifestation of a change in the α1-GABAAR system 
occurring during the course of the chronic drug treatment. This could for instance be 
adaptations in the channel desensitisation kinetics, or changes in receptor recycling to the 
membrane. There also remain possibilities that extrasynaptic receptors could be activated by 
GABA spillover, affecting the α1-mediated inhibition. We, also, cannot exclude that the 
influence of associative factors in relation to the drug-associated context, i.e. resetting of the 
context-specific changes in synaptic plasticity, in the expression of sedation during the 
course of the chronic zolpidem treatment regimen, as this was proposed for sedative 
tolerance to diazepam (Marin et al., 1999). 
 
W
another study has demonstrated that α1-binding sites are not changed even after 3 weeks of 
diazepam administration (Wu et al., 1994). Furthermore, neither acute nor chronic zolpidem 
administration reduced the number of α5-GABAAR binding sites as seen in diazepam-
tolerant animals (Fig 2). In keeping with its low affinity for α5-GABAAR, this result 
indicates that the reduction of the sedative efficacy of zolpidem with chronic treatment is 
independent of any change in these receptors. Thus, the mechanism of action underlying the 
chronic behavioral effect of zolpidem differs from that involved in sedative tolerance to 
diazepam. Chronic augmentation of only α1-GABAA receptor-mediated inhibition 
apparently is not sufficient to trigger down-regulation of α5 GABAAR. However, chronic 
diazepam treatment of α1(H101R) mice, with drug binding only to α2-, α3- and α5- 
containing GABAAR, also does not result in reduction of α5-binding levels (van Rijnsoever 
2004, previous chapter). As α2- and α3-GABAAR are not involved in sedation or tolerance 
to the sedative drug action, this implies that a tolerance-associated reduction in α5-
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GABAAR binding sites requires concomitant benzodiazepine binding to α1- and α5-
GABAAR subtypes. Interestingly, diazepam treated animals tested with zolpidem also did 
not show any change in α5 binding sites. The last drug binding to α5-GABAAR was, at the 
time of sacrifice, 23 hours ago. α5 Binding levels were reported to return to basal levels 2 
days after stopping a 4-week flurazepam treatment in rat. In the same study, the α5 binding 
levels also returned to normal after ending a 3-week diazepam treatment, albeit on a slower 
timescale (Li et al., 2000). The normal α5-binding levels observed in our mice could thus 
be due to lack of drug interaction with the α5-GABAAR subtype. However, since we did 
not test diazepam-treated animals with vehicle, we cannot exclude the possibility of a 
reversal by zolpidem of the α5 binding site downregulation associated with diazepam 
tolerance (Zanotti et al., 1999).  
 
In conclusion, these data confirm that drug-induced enhancement of phasic GABAergic 
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4 General Discussion 
 
In this thesis we used two strategies to investigate the regulation of GABAAR under normal 
conditions and after diazepam exposure. We assessed constitutive short-term regulation in 
cultured neurons. Furthermore, we examined the GABAAR subtypes that contribute to the 
development of sedative tolerance to diazepam. 
In the first work we demonstrated that in hippocampal cells constitutively endocytosed 
GABAAR are relocated to a pool located within the postsynaptic density. We conclude this 
from the observations that 1) the membrane needs to be permeabilised before the 
postsynaptic clusters can be detected, 2) the endocytosed clusters appear in a time-
dependent manner and 3) that their formation is inhibited when clathrin-coated vesicle 
mediated endocytosis is prevented. This intracellular pool might be involved in short-term 
regulation of GABAAR. 
 The major finding from our second study using point-mutated mice was that tolerance to 
sedation requires specific interaction of diazepam with both the α1- and the α5-GABAAR 
subunit, without any involvement of α2- or α3-containing GABAAR. Changes in α5 
binding sites associated with sedative tolerance were also only seen when both α1- and α5-
subtypes were available for diazepam binding. This was confirmed by the results obtained 
in wild type mice chronically treated with the α1-selective ligand zolpidem, which only 
displayed a partial sedative tolerance without any reductions in α5 binding sites. Thus, α1- 
and α5-GABAAR subtypes in particular mediate the development of sedative tolerance to 
diazepam. 
Below I will discuss the two lines of investigation and argue whether the constitutive 
mechanisms found in the first study could play a role in this sedative tolerance to diazepam.  
 
Constitutive GABAAR localisation and regulation in neurons. 
The effect of benzodiazepines is governed by the α−subunit of the GABAAR, with α1- and 
α2- GABAAR subtypes mediating sedation and anxiolysis respectively. In the 
hippocampus, α-subunits are expressed in different cell types (Fritschy and Brunig, 2003): 
the α2 subunit is mainly found in pyramidal cells, highly concentrated on the axon initial 
segment of cortex and hippocampal neurons and some clusters on the soma-dendritic 
compartment. The α1 subunit is highly expressed in hippocampal interneurons, but is also 
found at the soma and dendrites of hippocampal and cortical pyramidal cells. Although 
expressed in different cell types, the subcellular distribution of α1- and α2- GABAAR 
observed in hippocampal cell culture is very similar, since α1-subunits on interneurons and 
α2-subunits on pyramidal cells are both localized at postsynaptic sites (Brunig et al., 
2002a). Furthermore, we demonstrated that both the subunits accumulate at postsynaptic 
sites after internalization where they colocalize with gephyrin. In contrast to α1- and α2-
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subunits, the α5-GABAA receptor subunit is mainly extrasynaptic and does not cluster at 
ostsynaptic sites (Crestani et al., 2002). Efforts to investigate whether α5-subunits are also 
ght be a feature specific for subunits that 
). This agonist-induced endocytosis of AMPA R allows for fast 
al conditions, accumulation of internalized GABAAR at postsynaptic sites is not 
arnes, 1997) and 48 hours of GABA resulted in downregulation of GABAAR in whole 
ABA most likely do not 
p
endocytosed constitutively were unsuccessful. However, since no obvious clustering of α5-
subunits is detected in a normal staining, it seems unlikely that endocytosed α5- GABAAR 
accumulate in an intracellular pool as observed for the α1- and α2-subunits.  Thus, this 
intracellular pool colocalized with gephyrin mi
cluster at synapses. 
 
The constitutive endocytosis of GABAAR subunits is distinctly different from that observed 
with epifluorescence microscopy for the GluR1 subunits, which probably reflects the 
differential function and regulation of these two receptor types. First, GluR1 endocytosis is 
induced within minutes by agonist stimulation of AMPA R or NMDA R (Carroll et al., 
1999; Lissin et al., 1999
changes in synaptic strength and it is thought to be one of the mechanisms contributing to 
the development of LTP and LTD. In contrast, GABAergic transmission rarely seems to 
influence the localisation and constitutive endocytosis of GABAAR. In primary neuronal 
cultures mismatched clusters (GABAAR opposed to glutamatergic terminals) are observed 
(Brunig et al., 2002b) and blocking synaptic transmission had no effect on GABAAR 
clusters during synaptogenesis (Craig, 1998; Studler et al., 2002), evidence that synaptic 
clustering of GABAAR is independent of GABA activity. The lack of effect of regular 
GABAergic transmission on GABAAR localisation is consistent with our observations that 
under norm
influenced by blockade or acute enhancement of GABAergic activity. Although increased 
internalization after 1-4 hours of GABA exposure at 37°C has been shown (Tehrani and 
B
brain neuron cultures (Lyons et al., 2001), these exposures to G
happen under physiological circumstances. 
Another point in which GABAAR distinguish themselves from AMPA R, is their specific 
relocation to the synapse after their endocytosis, with very little clusters found within the 
cell body. Stimulation of AMPA R usually results in the rapid accumulation of GluR1 
subunits in the soma of the neuron (Carroll et al., 1999; Lissin et al., 1999; Beattie et al., 
2000). Over an hour after agonist exposure, most of these subunits are recycled again into 
the plasma membrane (Ehlers, 2000). However, although these subunits are able to return to 
the synapse again when degradation is inhibited, these endocytosed subunits lack the clear 
synaptic pattern observed with GABAAR subunits. 
It is not surprising that GABAergic transmission hardly affects the GABAAR localisation, 
whereas AMPA R respond so quickly and profound to glutamatergic transmission. The 
increased Ca2+ levels resulting from NMDA R opening can activate several proteins, such 
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as PKC or CamKII, whereas proteins that react to increased Cl- influx are not known at 
present. In contrast, indirect modulation of GABAAR can be rapid and involves receptors 
that can activate PKA, PKC or tyrosine-receptor dependent signaling mechanisms. Changes 
in GABAAR surface expression can be induced within 10-30 minutes via modulation 
through the following types of receptors: Activation of muscarinic achetylcholine receptors 
(Brandon et al., 2002b) or 5-HT2 receptors (Feng et al., 2001) reduced the GABA-activated 
response via a RACK1-PKC mediated mechanism. Stimulation of insulin, on the other 
and, rapidly increases surface GABAAR (Wan et al., 1997), possibly through activation of 
ce. It is known that tolerance to various effects 
s in the GABAAR so that a full agonist 
h
tyrosine kinase (Brandon et al., 2002a; Ma et al., 2003).  Thus the intracellular subsynaptic 
GABAAR that we detect might provide a way for fast regulation of GABAAR after 
modulation via phosphorylation-dependent mechanisms activated by other types of 
receptors. Adaptations through these second messenger pathways could possibly contribute 
to long-term regulation of GABAAR, e.g. during the development of tolerance to 
benzodiazepines.  
 
GABAA R regulation in the brain by benzodiazepines 
The several GABAAR subunits are not only expressed in different cell types, they also have 
their own subtype-specific localisation in certain brain regions. On a global level, α1- 
subunits are most abundant in the cortex, α2-subunits in striatum and hippocampus, α3-
subunits in olfactory bulb and cortex and the α5-subunit is highly enriched in the 
hippocampus (Fritschy and Brunig, 2003).   The major finding from our second line of 
investigation is that tolerance to sedation requires interaction of diazepam with both the α1- 
and the α5-GABAAR subunit. The molecular change associated with sedative tolerance, a 
reduction in α5 binding sites in the dentate gyrus, appears only with diazepam, which was 
able to bind to α1- and α5-GABAAR. It is unclear, however, whether this decrease is a 
cause for the restored motor activity or a consequence of adaptive, compensatory 
mechanisms that underlie the state of toleran
occurs on different timescales: whereas tolerance to sedation usually develops within a 
week, tolerance to the anxiolytic effect requires at least 3 weeks of treatment (Hutchinson et 
al., 1996a). It is therefore likely that different GABAAR subtypes are involved in the 
development of tolerance to sedation and anxiolyis. It will be interesting to determine 
whether α5-GABAAR are always involved. 
Several hypotheses have been suggested to explain the development of tolerance. One of the 
first was the idea of a ‘shift’ in benzodiazepine action, in other words, that chronic 
benzodiazepine treatment results in intrinsic change
would act as a partial agonist or even an antagonist (Stephens, 1995). This has been refuted 
by the fact that full allosteric agonist treatment does not result in similar amounts of cross-
tolerance (Rosenberg, 1995). Moreover, our results show that it is the GABAAR subtype 
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interaction, rather than the full agonist action, that determines the development of sedative 
tolerance. 
A second possibility that has been considered is a change in subunit composition: the total 
number of α1-binding sites does not seem to change after diazepam exposure (Wu et al., 
1994a); however, changes in mRNA and protein expression have been reported (Hutchinson 
et al., 1996a; Barnes, 2000; Costa et al., 2002; Biggio et al., 2003). These reductions in 
protein or mRNA expression could also be related to the drug used, as changes are often 
reported with flurazepam (Zhao et al., 1994; Tietz et al., 1999a; Tietz et al., 1999b). 
Changes observed after diazepam exposure are often with either high doses or treatments of 
14 days or more (Wu et al., 1994b; Holt et al., 1996; Impagnatiello et al., 1996; Pesold et 
al., 1997). Recently, it was shown that this reduction in α1-mRNA is specifically located 
within the dendrites, implying a local regulation mechanism for GABAAR expression 
(Costa et al., 2002).  Interestingly, α1-specific ligands are devoid of effects on mRNA or 
protein expression.  A decrease in α1-subunit mRNA was detected in cultured cerebellar 
ranule cells after 5 days diazepam exposure but not after zolpidem (Biggio et al., 2003). 
protein expression have been 
are the main cause for the development of 
g
Although changes in receptor subunit mRNA and 
demonstrated, it seems unlikely that these changes contribute to the sedative tolerance to 
diazepam observed in our mice. First, with the doses used in our study, we failed to detect 
any effects on total numbers of benzodiazepine binding sites. If changes in α1-subunit 
protein expression would occur (Impagnatiello et al., 1996; Pesold et al., 1997; Chen et al., 
1999), diazepam-tolerant α2(H101R) mice should reveal a change in binding sites as well.  
Interestingly, even the point mutation did not unmask any reduction in binding sites that 
might go unnoticed in wild type mice. Therefore we can rule out any major effects of 
diazepam on α1- or α2- containing benzodiazepine binding sites in the regions investigated. 
In the end, we could only detect a reduction in α5 binding sites in specific regions with a 
specific α5 ligand. Second, the motor activity of diazepam-tolerant wild type mice was still 
reduced by the α1-specific ligand zolpidem, implying that, even if α1-GABAAR subunit 
expression was reduced, this was not enough to result in loss of zolpidem’s sedative 
capacity. Last, an acute injection of the antagonist flumazenil is known to readily reverse 
the tolerance (Tietz et al., 1999b). Since the trafficking of newly assembled GABAAR from 
the Golgi to the membrane takes at least 6 hours (Gorrie et al., 1997), it is unlikely that 
changes in receptor subunit composition 
tolerance.  
A third explanation is that the loss of allosteric coupling between the GABA-binding site 
and the benzodiazepine-binding site of GABAAR is lost after chronic benzodiazepine 
exposure. This is called uncoupling (Klein et al., 1994; Friedman et al., 1996). The 
uncoupling hypothesis is in line with a fourth idea, that tolerance to benzodiazepines might 
be caused by receptor internalization (Tehrani and Barnes, 1997; Ali and Olsen, 2001; 
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Bateson, 2002). As uncoupling is measured using membrane-permeable benzodiazepines 
and the membrane-impermeable GABA, it is logical that internalization of GABAAR will 
daptations at the network level might be involved in the molecular and 
result in uncoupling, since the benzodiazepines can bind to intracellular receptors whereas 
GABA cannot. The presence of an intracellular pool of GABAAR directly under the synapse 
would provide the possibility to quickly recruit GABAAR to the membrane e.g. after 
flumazenil exposure. Autoradiography does not distinguish between surface and 
intracellular receptors, as the ligands we used are membrane permeable. A lack of 
benzodiazepine binding site reduction would not rule out a redistribution of GABAAR in 
diazepam-tolerant animals. Although α1-GABAAR endocytosis might occur during chronic 
benzodiazepine treatment, this is unlikely to result in full tolerance, as the α1-GABAAR 
were still pharmacologically active in diazepam-treated animals.   
Since none of these hypotheses for tolerance explain our results, we propose that the 
development of tolerance to the sedative action of diazepam is not due to a loss of 
GABAAR function, but to adaptive mechanisms, as discussed in the next section. 
 
Role of network and cellular adaptive mechanisms for the development of tolerance to 
diazepam 
Our results show that the function of α1-GABAAR is maintained in diazepam-tolerant 
animals, and that behavioral tolerance is accompanied by a reduction of a5-binding sites, 
which occurs only if the animals are treated and challenged with a ligand, such as diazepam, 
that activates α5- GABAAR. These findings suggest that signaling through α5-GABAAR is 
important for the induction and ‘maintenance’ of the tolerance state.  Since these receptors 
are mainly extrasynaptic, a chronic enhancement of tonic inhibition might be an essential 
component of the development of tolerance. The reduction of α5- GABAAR in the dentate 
gyrus might represent one of these compensatory mechanisms.  Indeed, the hippocampal 
formation is an important gateway interconnected with most of the neocortex. A reduction 
of α5-binding sites in the input area of the hippocampal formation is therefore likely to 
maintain a high level of activity at output stations (Chagnac-Amitai and Connors, 1989), in 
spite of the repeated enhancement of α1- GABAAR function by diazepam. Further adaptive 
responses are likely to occur in both the hippocampus and neocortex, as specific changes in 
NMDA R expression (Perez et al., 2003) and LTP threshold (Marin et al., 1996) have been 
reported after chronic benzodiazepine treatment. 
Although a
behavioral expression of tolerance to sedation, other mechanisms cannot be excluded.  For 
instance, since tolerance to the anxiolytic action of diazepam requires longer chronic 
treatment protocols, an important question raised by the present results is whether tolerance 
to anxiolysis is mediated by the α2-GABAAR and how it develops following the network 
adaptations which occur during the first week of treatment. The expression and regulation 
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of different GABAAR subtypes might be under control of distinct mechanisms that would 
be activated only after prolonged treatment. Recent research on 5-HT1A receptor- knockout 
mice revealed that these mice have an anxious phenotype. These mice were 
benzodiazepine-resistant, in other words, benzodiazepine treatment did not relieve the 
anxiety. It turned out that the expression of α2-GABAAR in the amygdala and cortex of 
these mice was reduced by 50% (Sibille et al., 2000). Thus, expression of GABAAR in 
amygdala is under the control of 5-HT receptors, likely via a PKA or MAPK signaling 
pathway. It is therefore conceivable that tolerance to anxiolytic action of diazepam involves 
a region-specific down-regulation of α2-GABAA receptor under the control of the latter 
signal transduction pathways 
Furthermore, the α1-GABAAR can be modulated by CaMKII, which causes increases in 
treatment. 
urthermore, changes in CaMKII expression have been demonstrated following diazepam 
erance (Huopaniemi et al., 2004).  Interestingly, CamKII is not expressed in 
 of surface and intracellular GABAAR on a 
phosphorylation and allosteric-modulator binding to GABAAR (Churn et al., 2002). It is 
speculated that CaMKII might be able to activate dormant, or intracellular receptors. 
Furthermore, changes in CaMKII are implicated in chronic diazepam 
F
treatment of wild type mice, but not in α1(H101R), which did not display sedation or 
sedative tol
interneurons (Sik et al., 1998), which are known to have the highest expression of α1-
GABAAR subunits (Gao and Fritschy, 1993), suggesting differential, cell-specific changes 
in α1-GABAA receptor function after chronic diazepam tolerance. Even in principal cells, 
regulation of the GABAergic response after PKC or PKA activation is differential 
depending on the brain region, as PKC reduces mIPSCs in CAI of the hippocampus, but 
increases them in dentate granule cells (Poisbeau et al., 1999). These alterations after 
chronic diazepam treatment are not incompatible with an overall preservation of the 
function α1-GABAA receptors, demonstrated by our results. They imply, however, that 
chronic diazepam treatment might differentially influence their role in principal cells and 
interneurons to produce the behavioral effects measured in the present study. 
 
Involvement of short-term mechanisms in long-term regulation of GABAAR 
As highlighted in the introduction, the cell-surface stability of GABAAR subunits depends 
on the phosphorylation of specific residues in the several GABAAR subunits. This provides 
an intricate mechanism for regulating the amount
short-term basis. This raises the question whether a short-term mechanism such as 
phosphorylation is implicated in the development of tolerance. It is has been shown that 
chronic benzodiazepine treatment increases the activity of PKA in hippocampus and that 
blocking PKA activity in a heterologous system results in an increased endocytosis of 
α1β2γ2 GABAAR.  How chronic benzodiazepine could change these second messenger 
pathways is unknown, however, changes in the balance of phosphorylation activity could 
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influence the GABAergic tone by its effect of cell-surface GABAAR. However, considering 
the involvement of adaptive mechanisms described above, it is likely that increases in 
phosphorylation activity have an effect on other types of receptors, such as the AMPA R, as 
well. This might influence the number of cell-surface of AMPA or NMDA R, resulting in 
changes of excitatory transmission that could counteract the drug-increased inhibition. 
 
Conclusions & outlook 
This study shows that there is an intracellular pool of GABAAR within in the postsynaptic 
density that could provide means for short-term regulation and, furthermore, that the α1- 
and α5-GABAAR subtypes contribute to the development of sedative tolerance, possibly by 
ult in sedative 
lerance.  
lerance, a 
activating adaptive mechanisms. Endocytosis of GABAAR was suggested as a mechanism 
for tolerance to benzodiazepines. The constitutively internalized GABAAR might stay in the 
intracellar pool within the postsynaptic density after chronic diazepam exposure. However, 
our results imply that endocytosis of α1-GABAAR is unlikely to be the main cause of 
tolerance, as diazepam-tolerant mice are still sedated by a single dose of zolpidem. The 
specific, concurrent involvement of α1- and α5-GABAAR suggests that the increased tonic 
inhibition via α5-receptors plays an important role in the development of sedative tolerance.  
More research is needed to answer some of the open questions of this thesis: 
1) We could not demonstrate any effect of acute application of agonists, antagonists or 
allosteric modulators on dynamic regulation of GABAAR subunits. It will be of importance 
to see with a biotinylation assay whether chronic administration of these compounds will be 
able to alter the rate of endocytosis or insertion in neurons. 
2) We demonstrated the role of α5-GABAAR in the development of sedative tolerance. At 
the present moment, very little is known about this extrasynaptic receptor. It will be 
important to know if α5-GABAAR display the same constitutive regulation and endocytosis 
as seen with the synaptically localized α1- and α2-GABAAR. One intriguing question is 
what the mechanisms downstream of the α5- GABAAR are that in the end res
to
3) Although internalization of GABAAR is no major contributor to sedative to
basic question that needs answering is how phosphorylation influences constitutive 
regulation of GABAAR subtypes. This has partly been assessed by the use of phospho-
specific antibodies for β subunits in a biotinylation assay (Jovanovic et al., 2004). As α-
subunits do not contain any sites for PKC or PKA phosphorylation, internalization of these 
subunits could be investigated with the biotinylation assay with PKC and PKA activators. 
Furthermore, it would still be interesting to see if chronic benzodiazepine exposure 
increases phosphorylation of specific GABAAR subunits, or if PKC/PKA activity is higher. 
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In conclusion, our data show that there are distinct pathways for short-term and long-term 
regulation of GABAAR. These data further our understanding of the dynamic regulation of 
GABAAR under constitutive conditions as well as in response to chronic diazepam 
treatment. 
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